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Introduction 
                         “஫றுப்பது உடல் ந ோய் ஫ருந்தென யோகும் 
        ஫றுப்பது உர ந ோய் ஫ருந்தென யோகும் 
                          ஫றுப்பது இனி ந ோய் tuhÂU¡f 
       ஫றுப்பது சோவலயும் ஫ருந்தென யோந஫”1 
 
              According to our ancient saints , health is a state of being well enough to 
function well physically ,mentally and socially. 
 
               Siddha system is not merely a compendium of therapeutics based on 
herbs, animals and mineral resources, it is claimed to be a philosophy of life and 
living. As per siddhars concept derangement of the three humours leads to diseased 
state. Prevention and cure are the basic aim of all systems of medicine whereas the 
siddha system has in addition the transcendental motivation i.e., immortality of the 
body using kayakalpa drugs 
 
               In India alone, the prevalence of diabetes is expected to increase from 
31.7 million in 2000 to 79.4 million in 2030. The prevalence of type 2diabetes is 4-
6 times higher in the urban areas as compared to rural areas. The prevalence of 
impaired glucose tolerance (IGT) in the rural population is also high at 7-8 %. This 
indicates presence of genetic basis for type 2 diabetes in ethnic Indian population
2
. 
 
               The disease “Madhumegam” is diagnosed on the basis of “Neerkuri”, 
Neikuri, Nadi Paritchai, Clinical, Pathological and Bio-Chemical 
Investigations. 
 
            In Modern clinical entity – “Diabetes Mellitus” closely resembles one 
of the variety of “Inippuneer” as “Madhumegam”.  It is a metabolic disorder 
8 
 
caused by absolute or relative deficiency of Insulin characterized  by polyuria, 
Polydipsia ,  Polyphagia , cellular dehydration etc. 
                    Malnutrition in childhood , obesity , truncal obesity in adults coupled 
with lack of physical activities ,high calorie fast food and the stress on youngsters 
leads to more prevalence of type 2 diabetes. 
 
                       WHO firmly believes the diet, lifestyle and medicines constitutes the 
triangle of treatment for diseases like diabetes and simple exercise like brisk 
walking,  swimming can help effectively in the management of the disease
3
. 
 
            The entire world is facing it as an outstanding problem and the 
disease which not only affects the rich but also the poorest. So I think that it is the 
right time to conquer the disease with siddha medicines . 
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AIM AND OBJECTIVES 
 
AIM 
     The aim of this study is to conduct a Clinical trial on madhumegam (Diabetes 
mellitus). To evaluate the safety and efficacy of the siddha trial drug NAVAL 
KOTTAI CHOORANAM on madhumegam (Type 1 diabetes mellitus). 
 
OBJECTIVES 
1. To review the Siddha literary evidences dealing with etiology, classification, 
signs  and  symptoms, diagnosis, diets, prognosis of Madhumegam in Siddha 
system of medicine. 
2. To study Madhumegam in various literature in comparison with modern 
Science. 
3. To understand the incidence of the disease with reference to age, sex, 
thinaigal, paruvakalam, socio economic conditions, diet and family history. 
4. To explore and utilize, the diagnostic methods envagai thervu, mukkutram, 
udal thathukkal with specific reference to Naadi, Neerkuri, Neikuri. 
5. To carry out a clinical trial with the siddha drug NAVAL KOTTAI 
CHOORANAM. 
6. Modern investigations should be done to access prognosis for before and after 
treatment of madhumegam. 
7. To systematically record the signs and symptoms and the test results of full 
evaluation. 
8. To assess the acute and sub acute toxicity of the Siddha formulations. 
9. To study the anti diabetic activity of the Siddha formulation and 
physicochemical analysis for safety and purity of NAVAL KOTTAI 
CHOORANAM. 
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REVIEW OF LITERATURE 
SIDDHA ASPECTS – MADHUMEGAM 
 
“j¡f jhuâ khål¤njhªfŸ nfŸ 
g¡f khry« g¤ÂUtifÍnk 
e¡f ehaf‹ eha»¡nf brhš 
ä¡fe¨Â és©ÃéÂ¤jnj”4 
 
According to therayar vagadam , “The universe consist of two essential entities that is, 
matter and energy which siddhars referred to as shiva and sakthi”. Shiva explained 
megarogam to sakthi. Here nandhi explains its symptoms to the world for the benefit of the 
human kind. This clearly indicates that the existence of this disease is as old as human 
races.  
“Mk¥gh kåjª brŒj f‹k¤jhny 
 mufuh nkfbk‹w  uhrhthny”5 
                                                                   
According  to siddhars ,the imbalance  of   tridosha     causes   totally 4448     diseases to   
human beings.  Among  them , megarogam  is  considered  to be the emperor of diseases. 
“Á¢»D© FiwæD© nehŒbrŒÍ© ünyhª 
të Kjyh v§âa _‹W”6 
 
All the disease are due to alteration of three vital humors and seven physical constituent. 
 The factors, which affect this equilibrium of vital humors are, 
 
• altered diet habit ( Unavu marupadugal) 
• Seasonal variation(kala marupadugal) 
• Depending upon immunological status( thega vanmai)   
 
           Madhumegam has its description in various literatures like Yugi Vaithya 
Chindamani, Agasthiyar Gunavagadam. 
Earlier, diseases were classified only according to mukkutram.  Yugi munivar classified the 
diseases according to cause, signs and symptoms, and also explained about the prognosis, 
treatment and diet, which is now followed by the modern world,he also followed the 
Mukkutram classification. 
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ntWbgaªfŸ( Synonyms) 
äFÚ® 
btF_¤Âu« 
Ïå¥ò Ú® 
            nkfÚ® 
kJnkf« 
Ãunkf« 
Ú®¥ghL 
ÚçêÎ 
Â¤Â¥òÚ® 
 
DEFINITION (IYAL) 
It is a clinical condition characterized by frequent passage of urine more than the 
normal resulting in deterioration and diminution of the seven thathus.     
“m§ikahao¡ fo¡F Úçw¦F 
ko¡fo¡F miuehê jåny fhQ« 
bt§ikahd joa jå‰wh‹ Ão¡F© 
ä¡fhd rl© btS¤J nkåf‹W©”7 
                                   
 These lines quotes frequent micturition, more than the normal with large 
quantity resulting in detoriation of gradual dimnision of sevan udal thathukkal. 
“Úçid¥ bgU¡fby‹W Úçê éy¡fz¦nfŸ 
ÚythçÂ ngh‰ F¡» Ú£o¡F Kiu jŸshF© 
Úé TlhJ if, fhš Úykh éid neuhF© 
ÚŸ brhdhÎuå‹ _¢R Úrkh Ka¦f¡fh£L©”8 
                    
                   Abdomen distends like sea, slurring of  speech peripheral neuritis, lassitude, 
dyspnoea are the symptoms of  Madhumegam.  
As per Athma Rakshamirrtham body becomes weak, weight loss, dryness of skin and 
tongue, excessive  thirst, tiredness, excess sleep indicate the presence of megaroham.. 
VERUPEYAR – SYNONYMS: 
 Neerizhivu,  Ennipu neer 
 Neerizhivu – Excess of urination9  
 Ennipu Neer – The urine is sweet in taste    
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NOI VARUM VAZHI-AETIOLOGY 
 
“nkfbkD ÚuêÎ tU« éj¤ij 
és©ò»nw‹ K‹brŒj fªk¨j‹dhš 
          jhfKl‹ kJgjhª¤j¦fŸ e‹whŒ¤ 
jh‹òÁ¤j yhYŠÁ‰¿d¤Â‹ k¦if 
 nghfkÂ fç¤jyh Y£od¨jh‹ 
nghjnt äŠRjyhš jæªnkhª beŒghš 
          VfkhŒ¥ òÁ¤jyh‰ bfhG¤j ñid 
ba‹W K§z YtªÚiu¡ Fo¤jyhny 
          MirÍl‹ ÁWtGjy¦fhŒ j‹id 
aÂfkh Í§gjhš fhy¨j¥Ãš 
nghrd¦fŸ  brŒjyhš eilaiy¢rš 
nghjnt æU¤jèuh f§éê¤jš 
     njrbk§F Âçjyh äitfshny 
     Áu¨jå‰N lÂf¦ bfh§Llnd u¤j© 
     nrhînj aÂfkhŒ nkf¨njh‹¿¤ 
      bjhšiy brŒÍ© ÚuêÎ© ÏUgjhnk.”10 
   
  
(i) Diet Habits 
 
         ”nfhija® fyé nghij   
bfhG¤jÛ åiw¢Á nghij                                                     
         ghJthŒ beŒÍ© ghY©   
 gçÎl  D§Ó uh»š 
          nrhjgh© LUt ä¡f 
   R¡»y Ãunkf¨jh‹                                                         
xJÚçêÎ nru  
t§bld t¿¨J bfhŸs”11 
 
 
“c‰gé¡F© ghš beŒah èiw¢Á fŸshš 
     cçirahŒ  Û‹w‹dhš  tUéU¤j 
k‰gé¡F© gjhª¤j¤  jhš kJu t«jhš 
                   k¨j¦fŸ jå‰ bghÁ¤jš ntfh¥  g§l© 
F‰gé¡F¦ Fë¨j t‹d k¦if nfhZo 
               F¿¤j ã¤ Âiujéªj y¡»å k¨j©”12 
 
 Excessive  intake  of  food  rich in carbohydrate and fat, red meat, sweet food, raw 
food and sleeplessness give raise to mathumegam quotes Agathiyar and Yugi Munivar. 
16 
 
(ii) Sexual Indulgence: 
“f‹å ka¡f¤jhš f§oL nkfnk”13 
 
“»u¨Â¥ ò§âuz  nkf¡ 
 Ðrf bd‹D¨ J‹ khª¡f‹ 
                                                     mU¨jÂ ba‹D© ghŠrhè  
                                       a‹idia¡ f§Q‰whnd”14 
According to Thirumoolar and Therayar, excessive indulgence in sex causes megaroham. 
 
(iii) Obesity: 
“j‰Ãé¡FŠ rßu¨jh‹ äf¥g U¡fš 
                   ršry¨jh‹ ga‹gLjš  jç¡F© nehna”15 
Obesity is one of the main cause of  Madhu megam. 
 
(iv) Psychosomatic  Cause: 
                                      “Ïa©gnt MWFs© Ã‹dŠ brŒjš 
      V‰wkhŒ Ãuhkz«Âß r¦f© g§zš 
ga«gnt ghy®fS¡ bfhë¤J¤ Â‹dš 
     gHit ry© nghw têjid¤ jL¤jš 
ma©gnt Nya¤Â‰ ry©é£l nlhª¡F© 
          MÂah© ntj¤ij  ¤öî‰  njhª¡F© 
                                       Ja«gnt Nçaid tz§  fhjh®¡F« 
          RU¡fh nkf© t¨J‰g  é¡F¨jhnd”16 
According to Yugi Vaidya Chinthamani, Megaroham  may occur due to not giving proper 
respect to Guru, Father, Mother, Vedas and  suriyangod. 
V. Hereditary: 
“Kiwnf£»š x‹gJ Ka‰Áahš t¨jJ 
                   Jiw nf£»w fU¥g¤Â‰ Wt¦»a nkf¦fŸ 
          ãiw ó¤j bfh¦ifahŸ ehaf‹ nkhf¤jhš 
                     kiw ngh‰W¦ fU¥g¤Âš tsª¨jJ nkfnk”17 
Thirumoolar have noted in their literatures  that  Hereditary is one among the causes of the 
disease Madhumegam.Present day researchers have found out that genetic factors play an 
important role in Madhumegam. 
 
vi.  Excess Stimulation of Moolatharam: 
 
rçahdnkf¤jh yghd thÍ 
                         jh‹ òif¡F nkny¿¡ fghy¢ Nlh© 
bgçjhd nkf¤jh y¤Â btªJ 
                 nghk¥gh jirbt¨J u¤j© t‰¿¥ 
             gçth»¤ jr thŒthš k¨j¦ bfh§L 
17 
 
           bgUªÔå  kygªj« cjhd thÍ 
      éçth»¤ njfbkšyh© él % uhny 
                 bkŒaê¨j njfbk‹w ÂUgjh¢nr”18 
 
Among the six Atharams  the Moolatharam is situated in between rectum and  genitals, just 
end of sacral plexus. 
In the Madhumegam disease, impaired Abana vayu (excretory junction) inactivate the 
moola agini during that time excess intake of food causes inactivation of dhasavayu  which 
create excessive appetite (Polyphagia) and constipation.  Udanan is also affected.  These 
changes in turn causes the derangement of seven  udal  thathukal. 
vii.Deeds: 
 “jhnd  óUt éÂædhš rhU© Ãâf bsšyh© 
                          khndª éêahŸ nt£ifædhš tU¨J© Ã‹D© gÁahš 
                    jhnd bghW¤J c§ifædhš jhf¨j‹dhš äf¢nrhª¨J 
                        jhnd fky© ò§zh» brŒÍ© Ãunkf¢ brašjhnd.”19 
From the above poem, the diseases also occur as a result of bad deeds committed in 
previous or this birth.  
MURKURIGUNAM  (PREMONITORY SYMPTOMS): 
 
Premonitory symptoms of Madhumegam are poly uria, poly phagia, poly dipsia. 
Madhumegam exhibits the following premonitory symptoms from its initial stage of 
development itself.  The patient experiences voracious hunger, thirst, perspiration, 
exhaustion and giddiness.  The excessive intake of water to quench his thirst is excreted as 
excessive quantity of urine (poly uria).  In spite of abnormal consumption of food, stamina 
continues to decrease.
20
 
kJnkf« bghJ F¿Fz«: 
                                   Twhd nkfkJ ÏUgJ¡F« 
    Fz¨j‹id¢ Át‹brhšy njé nf£f 
                                  jhwhd jhfbkhL nrhfnkfª 
                                jçahkš Úçêj  éUkš _¢R 
                                  Mwhd mUÁr¤Â Á¤j¥  u«ik 
           mofo¡fo¡F¤ j§Ùªjh‹ m¦nf nf£fš 
                                  <whd ÏL¥ò¡FŸ fL¥ò fhzš 
                                        vY©òH‰w yH‰wy blçÎ lhnk 
                                  vçnthL rßubkšyh kiwg£lh‰nghš 
                                        vY©ò nehjš ã¤Âiuæš yhik 
                                 tçnthL khŒébk¤ jÎ©g¿¤jš 
                                        kdJrŠ  ry¥gLjš  fh‰W nt§lš 
                                 bkçnthL nkš _¢R äfÎ§lhjš 
18 
 
                                        é¡fbyhL ka¡f¨jh‹ bk¤j¡ fhzš 
                                 bjçnthL njfbk¦F© btSU§lhjš 
                                         njfbk¤j thnyhg¥ gLjš fhnz”21 
Common Symptoms: 
Thirst   Polyuria 
Poly dipsia   Cough 
Anorexia   Dyspnoea 
Delirium   Pain in the hip and burning sensation 
Sleeplessness  loss of weight 
Hiccough   Flatulance 
Anaemia   Giddiness 
 
NOI VAGAIKAL- (CLASSIFICATION) 
 
Megarogam  is classified into twenty varieties to quote from Agasthiar 
 
 “c£oz nuhf¤jhY© cW©bgU© gÁædhY¦ 
   f£léœ  nfhij khjª fyék£oyh ikayhY 
   K£lwh ehYkhW K© _‹W bkh‹W bkh‹W 
   Â£lkhŒ tUtbj‹W ÂUKå aUë¢ brŒjhª”22 
 
Yugi Munivar classifies the same as 
trå¤j nkfkJ æu©L g¤J 
           thj¤Â‰ Ãw¨jry© ehnyahF© 
                                             Ãrå¤j Ã¤j¤ÂY  ‰wgé¤j 
  nguhir yªjhD khW khF« 
                                             njrå¨j nr£Lk¤ÂY‰g é¤j 
       Óuhd ryªjhD« g¤njahF«.
23 
 
According to Theraiyar 
  
“fêÍ© thj© eh‹fhY©  fhÍ© Ã¤j khwhY© 
                                       RêÍ© nr¤Jk© g¤jhY© brhšY© ehyŠrhŒ 
njh‹W©”24 
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NOI VAGAIGAL 
Books Noi enn Vali Azhal Iyam 
mf¤Âa® 1200 20 4 6 10 
ô» it¤Âa Áªjhkâ 20 4 6 10 
njiua® thfl« 20 4 6 10 
j‹t¨Âç it¤Âa© 20 4 6 10 
rungªÂu ÚçêÎ nuhf Á»¢ir 20 4 6 10 
ô» Kå it¤Âafhéa« 20 4 6 10 
 
The above books describe twenty different kinds of megam (urinary disorders) on the basis 
of colour, consistency, taste, smell, weight etc. 
   Out of this twenty different kinds 
   Four varieties are caused by vali 
   Six varieties are caused by Azhal 
   Ten varieties are caused by Iyam 
 
Madhumegam comes under the classification of Azhal. 
 
Classification of Megam: 
According to Yugi Vaidhya Chinthamani 
thjÚª tiffŸ 
“jç¤Â£l thj¤Â‹ ry¨jh dhY 
                  jåahd ehY¡F© ngnu bj‹åš 
      mç¤Â£l M¢ÁabfªÂ nkf¤njhL 
          mj‹ÃwF R‰wkh  nkfbk‹W 
                                             Ãç¤Â£l Ãuäa nkfbkh‹W 
         nguhd kh¦fué nkfbk‹W25 
 
Vali – 4 
1.  Neimananeer 
2.  Pasumana neer 
3.  Seezhmana neer 
4.  Sathaimana neer 
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Ã¤j Úª tiffŸ 
Kiwahd Ã¤j ry khWkhF« 
                             KÂª¨j m¥Ãa bk‹W© Ãuäa bk‹W© 
        Jiwahd rh©ÓªzkJ©g bk‹W© 
                          rh¤Âfnk ahWéj¨  j‹ndh lhW”26 
Azhal – 6  
1. Yanai kozhupu mana neer 
2. Katrazhai mana neer 
3. Chunna mana neer 
4. Innipu megam 
5. Palingu neer 
6. Muyal kurithi neer 
 
IaÚª tiffŸ 
“Mwhd Ány£gry© g¤J j‹id 
                                  mu‹ brhšy M¤jhŸ jh‹ nf£F© nghJ 
                                              thwhd trhnkf« c¤rnkf« 
            k¢Áahnk  f¤njhgh Ñj nkf« 
                                             öwhd Ruhç R¡y K¤j nkf« 
                     R‰wkh©Ã  dhåbahl  tyz nkf© 
nfwhd  bjÍ¤jakh nkf bk‹W 
                                 br¥Ãdhª Ány£ g¤Â‹ brY¤J¤ jhnd”27 
 
Iyam – 10 
1. Iaya Neer 
2. Thuimai Neer 
3. Moolai neer 
4. Ilaneer 
5. Kal  neer 
6. Thavala Neer 
7. Kazhu neer 
8. Then neer 
9. Uppu neer 
10. Kavichi Neer 
21 
 
Yugi described four types under the Vatha premeham, six types under the pitha prameham 
and ten types  under Kaba prameham. “Diabetes mellitus” a clinical entity in a modern 
medicine is closely resembles one of the type of pitha prameham ie “Madhu Megam”. 
 
NOIKURI KUNANGAL – (CLINICAL FEATURES) 
 
Polyurea, Polyphagia, polydipsia, perspiration, exhaustion, insomnia, giddiness and loss of  
weight  even at normal consumption of food. 
 
Common sign and symptoms of Pitha Prameham 
“m¿ant  Ã¤jry khW¡F¨jh‹ 
                                m¦fkÂ‰ brŒ»‹w Fz¤ij¡ nfshŒ 
       j¿ant rßu© t‰¿ baçÎ§lhF© 
                             rl¤ÂY¨ ÚçY¨jh‹ fé¢R§lhF©. 
            bj¿ant  Ñ¥nghY¦ f‰whiH nghY© 
                                 nrš  nghY¨ nj‹ nghY© eh‰w K§lh© 
             bt¿ant  Ór¤Â‰ nfhr¤Â‰ Fj¤Âš 
                 äFÛuš ehÃæY© nt¡fh lhnk 
                       nt¡fhlhŒ éuz K§lhŒ thŒjh‹ ehW© 
                         é¡fbyhL mUÁaha¢ RuK©lhF« 
                                      Ò¡fhlhŒ¤ njf¨jh‹ »ilbfh£lhJ 
                                Âa¡fbkhL  _®¢irÍ©lh ka¡f khF« 
     rh¡fhlhŒ  ehtw¨ j§Ùª jhf© 
                         r¡ÂbahL  rßubkšyh¨ jsª¢Á ahF© 
             jh¡flh kyrŠry¨jh‹ äfÎ§lhF© 
                  rkFz¨jh‹ Ã¤j ry khW kh¢nr28 
As per the above poem, polyuria, polyphagia, Polydipsia, fever, angular stomatitis, pruritis 
vulvae, balanoposthtis, burning sensation all over the body, loss of weight, are common 
signs and symptoms of pitha prameham. 
MUKKUTRAIYAL: 
“Vadhamai Padaithu, pitha vanniyai kathu 
Seethuma Seethamai thudaithu”29 
Vali: 
Sites of Vadha: 
Below Naval, Urinary bladder, intestines, Pelvis, umbilical cord, thigh, bone, skin, nerve 
endings, joints, Musculature, hair root.Properties : 
Dryness                           Lightness 
Clearness                         Coolness 
Mobile                             formless. 
22 
 
Function  
 Praanan (uyirkaal) : 
          This controls knowledge, mind and five sense organs, which are useful for breathing 
and  digestion. 
 Abaanan (Keezh nokku kaal) :  
This is responsible for all down ward movements such as passing urine, stools,  semen, 
menstrual flow etc 
 Samaanan (Nadukkaal) :  
        This aids in proper digestion. 
 Viyaanan (paravukaal): 
       This is responsible for all movements of all parts of the body. 
 Uthaanan (Mel Nokkukaal) : 
Responsible for all upward visceral movements, such as vomiting, eructation and 
nausea. 
 Naagan :  
 Responsible for opening and closing the eyes. 
 Koorman :  
 Responsible for vision and yawning. 
 Kirukaran : 
 Responsible for salivation, nasal secretion and appetite. 
 Devathatthan :  
 Resposible for Laziness, sleeping and anger. 
 Thananjeyan :  
 Produces bloating of the body after death.  It escapes on the third day after death 
bursting out of the cranium. 
In Madhumegam 
Pranan :  Normal 
Abanan :  Constipation, Noctural  polyuria, frequency of micturation.  
  Viyanan         :  Symmetrical sensory disturbances, Peripheral  neuritis, pain all over the 
body.   Burning sensation in the sole of foot and palm, skin infection and 
carbuncle. 
   Udanan         :            Normal  
              Samanan  :  Poly Phagia 
                 Nagan            :           Normal 
                Koorman        :            Diabetic retinopathy / Cataract 
      Kirukaran        : polyphagia 
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         Devathathan   :        Laziness 
         Thananjeyan   :          - 
 Azhal: 
Sites of Pitha: 
 Between the heart and the naval, sweat, lymph, blood, stomach,  urinary bladder, 
heart, saliva, eye and skin. 
Properties: 
 Dry, cold, hot, light, subtle, keen, soft, liquid, bitter. 
Function 
1. Anal Pittham  : It promotes appetite and helps in digestion. 
2. Ranjagam                   : It gives colour to the blood. 
3. Praasagam      : It gives complexion to the skin. 
4. Aalosagam     : It brightens the eyes. 
5. Saathagam     : It controls the whole body.  It has the property to   
                                        fulfill all the activities which the mind desires. 
In Madhu megam 
 Anala Pitham    - Excess hunger 
 Ranjaga pitham - Pallor sometimes 
 Alosagapitham - Dimness of vision 
 Saathaga pitham - Lassitude 
 Prasaga pitham - Dry skin 
 Iyam: 
Sites of Kapha:Above the heart, stomach, fat, sperm, tongue, uvula, bone marrow, blood, 
nose, nerves, bones, large intestine, eyes, joints. 
Properties: 
 Heavy, cold, mild, watery, sweet and stable . 
 
Function  
1. Avalambagam     : Lies in the lungs, controls the heart and other    
                          kabhams. 
2. Kilethagam          : Lies in the stomach, makes the food moist, soft and  helps in digestion. 
3. Pothagam        : Responsible for identifying taste. 
4. Tharpagam          : Present in the head and responsible for the coolness of both eyes. 
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5. Santhigam           :  Responsible for lubrication and free movements of joints. It is situated  
                               in the joimts 
 
In Madhumegam  
 Avalambagam             -  Normal 
 Tharpagam  - Burning sensation in the eye 
 Santhigam  - Joint pain 
 Kilethagam  - Excessive appetite 
 Pothagam  - Normal 
 
 Seven Udal Thathukkal (Physical constituents)  
Annamaya kosa is constituted by seven thathus.They are the basic tissues of our body. 
 
Normal functions: 
Saram: 
 It is responsible for the growth and development.  It keeps the individual in good 
spirit and it nourishes the blood. 
Senneer: 
 Blood imparts colour to the body and nourishes the muscle responsible for the ability, 
intellect of the individual. 
Oon: 
 It gives shape to the body according to the requirements for the physical activity, 
nourishes fat. 
Kozhuppu: 
 It helps in lubricating the different organs and maintains only matter of the body. 
Enbu: 
 Supports the system and responsible for posture and movements of the body. 
Moolai: 
 It fills the bony cavity, nourishes semen, imparts strength endurance and shining 
appearance. 
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Sukkilam / Suronitham: 
  It is responsible for reproduction.  In healthy people, they function in a harmony, 
while in diseased people, they are deranged. 
 
 
In Madhumegam: 
 Saaram             : Tiredness, General weakness 
 Senneer  : Pallor 
 Oon   : emaciation 
 Kozhuppu  : Dry skin 
 Enbu   : Later stage due to infection it affects the   
                             bone and sometimes leads to amputation. 
 Moolai               :  Affected in Chronic stage. 
Sukkilam / Suronitham: Impotence, Sexual urge is reduced. 
 So, in Madhumegam, Seven Udal Thathukkal are deranged. 
MUKKUTRA VERUPADUGAL-(SIDDHA PATHOLOGY):  
          The disease megaroham, due to external (or) internal causes affect balance in the 
ratio of  vali, Azhal, Iyam.  This imbalance affects the Keelnokkukal, which inturn affect 
the seven udal thathukkal.   Saram gets affected and there is loss of appetite.  Seeneer also 
get affected with the  net result even if the patient eats more nourished food (polyphagia) 
there won‟t be any improvement in health. 
 An imbalance in pitham does imply an imbalance in other two kutrams too and causes 
derangement of dasa vayu and seven udal thathukkal which cause the disease and other 
complications. 
PINIARI MURAIMAI- (DIAGNOSIS): 
 Diagnostic methods in Siddha system are very unique and solely based on clinical 
acumen of the physician. 
1. Poriyal Arithal (or) understanding by the fire organs of perception (Mei, Vai, Kann, 
Mooku, Sevi) 
 2.      Pulanal Arithal (or) understanding by the sense objects (Uraithal, Suvaithal, Parthal, 
Mugarthal, Kettal)
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3. Vinadal (or) Interrogation 
 Tools used by Siddha Physicians: 
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(1) Kanndal (Perception) 
(2) Karuthal (Inference) 
(3) urai (The instruction of the inspired)31 
The application of these three is very extensive in diagnosis and treatment. 
 
Enn Vagai Thervu (Eight tools of Diagnosis) 
Naa: 
 Colour of the tongue, size, shape, anomalies, surface, mobility and local lesion should 
be noted. Coating deposition of the tongue, increased salivation, dryness of the tongue. 
In Madhumegam, the tongue remains dry and at times black. 
Niram: 
 Colour of the skin all over the body, a local region of affection, conjunctiva, tongue, 
nail bud, hair etc. 
 Vatha Udal  - Black and whitish colour 
 Pitha Udal  - Yellowish (or) Reddish colour 
 Kapha udal  - White or golden colour 
 Thontha udal  - Mix of two udal colours 
In Madhumegam, the colour of skin is different from original complexion, 
discoloured. 
Mozhi: 
 The quote from Agasthiar Vallathi 
 “thª¤ijia¥ ghª” 
 Observation of speech and voice. 
 In uncontrolled Madhumegam which leads to cerebrovascular disorder, 
speech disorder sets in. 
Vizhi: 
 Colour, character, vision  should be observed. 
 In uncontrolled Madhumegam cataract set in last.  In longstanding cases, the 
Madhumegam affects retina and causes diabetic retinopathy which is the major cause 
of blindness. 
Sparisam: 
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  Colour of the skin  (Vali, Azhal, Iyya udal), Eruption, Hemorrhages, Ulcers,    
Boils, trophic changes, in the skin can be identified. 
 Any changes in the internal organs can be noted by palpation (or) percussion. 
 In Madhumegam, increased tendency for fungal infection like moniliasis and 
vulvities. 
 In Madhumegam the skin is dry and pale. 
 
Malam: 
 Quantity, colour, smell, froth should be observed. 
In Madhumegam, constipation sometimes yellowish loose stool are passed. 
 
Muthiram: 
 Quantity colour froth smell and specific gravity of urine should be noted. 
Urine: 
Colour: 
 In Madhumegam clear and white. 
Specific Gravity: 
 In Madhumegam, urine is thick in consistency like honey. 
Smell: 
 Honey like smell 
Froths: 
 In Madhumegam the urine is frothy at the time of urination. 
Deposits: 
 In Madhumegam few epithelial cells are present in urine. 
 Normal quantity of adult urine is 750 – 2500 ml in 24 hours. 
 Disturbing   polyuria at night (nocturia )and  Glucosuria( the presence of sugar in 
urine)  are present. 
Ú® ãw¡F¿: 
“mU¨J kh¿ujK© ménuhjkjhŒ 
           m~fš myªjš mfhyñ‹ jéª¨jH‰ 
                                              F‰wstU¨Â cw¦» itfiw 
                                              Mo¡fyr¤ jhéna fhJ bgŒ 
      bjhUKTª¤j¡ fiy¡F£gL Úç‹ 
             ãw¡F¿ beŒ¡F¿ ãUä¤jš flnd”32 
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Collection of Sample Urine: 
 The patient must take well cooked food in the previous day.  The intake must be 
proportionate to the degree of his appetite.  Food intake should be taken, at appropriate 
time.  The patient  must have sound sleep on the previous night.  The urine is collected on 
the dawn of the next day in a glass container and closed immediately to prevent 
contamination.  This specimen must be examined with in one and half hours.  This 
procedure should be followed strictly to get accurate observation of Neerkuri and Neikuri
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beŒF¿: 
“ãw¡F¿¡ Fiu¤j ãUkhz Úç‰ 
                   Áw¡f bt§bzŒnahª ÁWJë eL éL¤ 
             bj‹Dw¤ Âw¨jbtë nafh  jik¤jÂ 
     å‹wÂtiy ngh© be¿éêa¿Î© 
       br‹wJ òfY¨ brŒÂia Íznu” 34 
NEIKURI: 
 The diagnosis and prognosis of deranged Mukkutrams are studied on the basis of the 
behaviour of a drop of gingelly oil gently droped on the surface of the urine kept in a wide 
vessel in the sunlight. 
“K¤bjh¤J ã‰»‹ bkhHtbj‹ fgnk”35 
In Madhumegam, the oil dropped in urine is like a pearl and if the oil spreads slowly, 
the prognosis of the disease is slow and good. 
eho: 
 Pulse diagnosis is the confirmatory diagnosis.  In Madhumegam, 
ÏUäna Ã¤jK© thjK¦ Tooš 
                                             kUÎry nkf« thUÂ nghyhF« 
      cUt© ntwhU K§lÎl‹ fh¨ÂL© 
          cUfnt ñndhL c¿ŠÁ Ïå¡Fnk”36 
Coupling of  Azhal and vadha  naadi causes excessive urine as vast as sea, loss of weight 
and polyphagia . 
When  kabha  merges with vadha  ,glucosuria,emaciation ,anaemia develops.
 
              ghª¤ÂL  _‹W© gÂ¨J   bkè¨J   ã‰»š 
                       njª¨ÂL  nk t¨  njh‹¿na    bghU¨ÂbkŒæš37 
 
when all  the  three nadis ,runs in low volume,diabetes develops. 
kJnkf Fz«: 
         “Ïå¡»‹w  thj¤ Âilnrçš Ia¨jh‹ 
        gå¡»‹w fŸS¥ gjånghš ÚnuhL© 
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        få¡»‹w nkå fiu¨J btS¥ngW© 
    jå¡F© kJnkf¨ j¥ghJ Iand”38 
 
   The coupling of  the Vali and Iya naadi,causes increase in urination,and  diabetes 
develops. 
 
 
 
ÚuêÎ nehæš fhQ© mt¤ijfŸ: 
 The following complication follow gradually. If the disease is not controlled (or) left 
untreated. 
mt¤ij – 1 
“fhznt Kjty¤ij¢  rßu¨  jhD© 
     fdkhf¥ gU¤ÂWF Ú®¤J thu« 
        ntznt bt§lh¡» afy© g§Q©”39 
Obesity sets in. 
         There is obstruction in urinary flow. 
         Urinary passage expands due to inflammation. 
mt¤ij – 2 
“ ä¡f Ïu§ lhkt¤ij és©g¡ nfshŒ 
_znt _¤Âu¥ ÔilÍkh¢ R¡y 
 KfkG»¤ nj#Rjh‹ äfnt F‹W©”40 
Micturation is frequent. 
         Sexual desire  gets. 
        There is also loss of complexion. 
mt¤ij – 3 
“ehznt  _‹whF  kt¤ij¡ F¨jh‹ 
ehtwS© thÍtJ ÛW¨jhnd”41 
Tongue generally becomes dry. 
 Abdomen is distended due to flatulence. 
mt¤ij – 4 
                                         “jhdhd ehyt¤ij a¦f jhf© 
                                                r‹åaJ ghj K§lh©”42 
Severe thrist occurs. 
 Causes delirium 
mt¤ij – 5 
                                                          “I¨J t¤ij¤ 
  njwhd Ú®bgUfª jhJ eZl«
43 
Quantify of urine increased. 
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 Loss of semen (impotence). 
mt¤ij – 6 
              “  ãiy ahwh kt¤ijÍl‰ »il bfhŸshJ 
 _dhd _®¢ir tU©”44 
Sleeplessness is present. 
 Difficulty  in breathing is experienced. 
 
 
mt¤ij – 7 
“VGt¤ij 
ä¡ftnuh ÁfŠRthr¨ njf rh£a©”45 
 Tongue becomes tasteless. 
 Difficulty in breathing is experienced . 
 General weakness persists. 
mt¤ij – 8 
“Vdhd v£lht jt¤ij jhnd 
                                    vG»u¨Â ÃsitÍ¨jh‹ äfÎ§lhnk”46 
 Abscess is formed. 
 Presence of Carbuncle . 
mt¤ij – 9 
           “c§lhF bkh‹gjh kt¤ij nfshŒ 
                             xG¦fhd Mrhu¦ »Uä Í§lh©”47 
Irregularities in daily habits like bowel habits. 
 Bed sore may occur. 
mt¤ij – 10 
          “g§lhd g¤jh¨j it¤ij¡ nfshŒ 
                          ghukh©  ra¦f§L gu¤J¡nfF©”48 
Secondary infection like tuberculosis may sets in due to loss of immunity,
 
Other complication  leading to death may occur. 
These are the complication at 20 Madhumegam. 
Other complications: Meganeer Kattigal 10. 
 Madaku Katti 
 Ammaiodu Kattai 
 Valai Kann Katti 
 Athomuga Katti 
 Pei surai katti 
 Kadalai katti 
 Kadugu Katti 
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 Vithirathi Katti 
 Nilapoosani katti 
 Megavithirathi katti 
 
ÔU«  Ôuhjit  (Prognosis) 
                                brŒant t¢rukh¨ j§l khd 
                 brakhd KJFj§il¥ g‰¿ ã‰F© 
                                bgŒant bgUeu©Ãš nkf¨jhD© 
                      Ãw¡Fbk‹nw jhd¿¨J thj¨j‹dhš 
                                ÃŒant Ãw¨jfy  khwh yrh¤Âa© 
           Ã¤j¤Â‰ Ãw¨jry khW© ah¥a© 
                               igant  nr£Lk¤Â‰ Ãw¨j g¤J© 
            gukDiu¤ jhª rh¤a© guhgç¡nf”49 
 
                                “têÍ© thj©  eh‹fhnk  
                                                  khwh jéœj¨ j‹dhny 
                                  bghêÍ© thj©  ãšyhJ  
          nghnk kU¨ij¥ bghŒbadnt”50 
The four types of megam caused as a result  of  imbalance  of vali are incurable. 
The six types of megam arising with disparity of Azhal could be cured with great  difficulty. 
But ten types of megam arising due to Iyyam are curable. 
                        v¨bj¨j nuhf¦fëš ÁWÚª mÂfç¤jhY© Fiw¨jhY© 
ÔJ? 
    “bt¥ò  Ãâajåš bt©nkf¤jhš tU¨Â‹ 
                                      j¥ò äif Únu jhåw¦»‹ - br¥ò« 
                                      »uhâæ‰ gh§oš FsªÚª RU¦»‰ 
                                      Ãuhz‹ ÃçÍbkd¥ ngR”51 
Very excess of urination in Megaroham causes death. 
                            “JÂ¥ghd nkf¤Âš ÚçêÎ khfh 
                    njh‹¿a  ÚçêÎ j§Ùª thjKkhfh”52 
If  Megaroham is associated with excessive urination, it is difficult to cure.  If  megaroham 
coexist with vali it is incurable. 
“nkf¤Âš ÚçêÎ nkÎkÂš thj nehŒ 
           ntf tæ¤JŸ tæ‰WisÎ – nrhf é¡fš 
                     g‹D é¡»š j‹åš gfçis¥ò¥  gh¦f jå‰ 
                                            Ã‹dis ahfhJ ngR”53 
If  in complications of  Megaroham with carbuncle, Morbid thrist, excessive body 
heat, shock and sweat occurs and the prognosis is bad. 
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“ntªitjå‰ fgK© nkÎkÂš é¡fš nehŒ 
       fhªK»š neª T¨jyhŒ f§L nkš – ÑªbfhŸ 
                                     kU¤Jt¤Â‰nwª¨j kÂÍilahuhé 
                                     jç¤Âuh bj‹gªrç”54 
 
If Iya megam is associated with sweat hiccough, the prognosis is bad. 
Maruthuvam: 
The treatment in Siddha Medicine is aimed at keeping the three kutrams (Vali, Azhal 
and Iyam) in equilibrium and maintenance of the seven udal thathukal. 
         In siddha science, the treatment is not only for removal of the disease, but for the 
prevention and improving the body condition after the removal of the disease. 
This is classified as 
 Kappu (Prevention) 
 Neekam (Treatment) 
 Niraivu (Restoration ) 
Kappu: 
 Prevention is better than cure is a proverb.   Siddha principles based  mainly on 
prevention as mentioned in “Theraiyar pini Annuga vithi” by Theraiyar. 
 The aim of the treatment is to bring the affected thathus and Mukkutram to normal 
levels by eyamma, niyamma, diet and medicine. 
Neekam 
 For the disease Madhumegam,NAVALKOTTAI CHOORNAM-1gm twice a day  is 
given . 
 
Niraivu: 
 Physical, Psychological, social and economic rehabilitation of individual is known as 
Niraivu. 
 In Madhumegam, Azhal kutram and other two kutrams Vali and Iyam deranged and 
causes impairment of dasavayu which in turn affect the seven udal thathukkal. 
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MODERN ASPECT 
Diabetes Mellitus 
Definition: Diabetes Mellitus is one of the most common endocrine disorders.It is a clinical 
syndrome characterised by hyperglycaemia with or without glycosuria,resulting from an 
absolute or relative deficiency of insulin, affecting carbohydrate,protein and fat 
metabolism.It may be due to impairment of insulin production or its release by Beta cells of 
islets of Langerhans. Long standing metabolic derangement is associated with functional 
and structural changes in many organs especially the vascular system leading to Diabetic 
retinopathy, Neuropathy and Nephropathy and Atherosclerosis
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AETIOLOGY 
 “Diabetes Mellitus” was considered to be due to a lesion in the Islets of “langerhans 
resulting in deficient output of Insulin.Insulin hormone is secreted at pancreas, which is a 
compound racemose gland.  The Islets of langerhans consists of the  beta cells (70-80%) 
and alpha cells (20-30%). The islets are more numerous in the tail part of the pancreas.  
Beta cells secrete insulin and alpha cells secrete glucagons.  Insulin is a soluble protein, first 
identified by Banting and Best in 1920.  Insulin acts by increasing the withdrawal of 
glucose from the body fluids and also by reducing the addition of glucose into the body 
fluids.  The increased withdrawal is carried out by deposition of glycogens in the liver and 
muscles, by enhancing the oxidation of glucose to carbondioxide and water and conversion 
of glucose to fatty acids (lipogenisis).  It also depress  neoglucogensis  (Conversion of 
protein and fat into glucose).  The most important stimulus for the release of Insulin is the 
blood sugar level. 
Anatomy of Pancreas 
The pancreas is a compound racemose gland, analogous in its structures to the 
salivary glands, though softer and less compactly arranged than those organs. Its secretion, 
the pancreatic juice, carried by the pancreatic duct to the duodenum, is an important 
digestive fluid. In addition the pancreas has an important internal secretion, probably 
elaborated by the cells of Langerhans, which is taken up by the blood stream and is 
concerned with sugar metabolism. It is long and irregularly prismatic in shape; its right 
extremity, being broad, is called the head, and is connected to the main portion of the organ, 
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or body, by a slight constriction, the neck; while its left extremity gradually tapers to form 
the tail
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Situation: 
It is situated transversely across the posterior wall of the abdomen, at the back of the 
epigastric and left hypochondric regions. 
Extent: Concavity  of duodenum to the hilum of the spleen. 
Length:  Its length varies from 12.5 to 15 cm 
Weight:  its weight from 60 to 100 gm. 
Duct System 
Pancreas has a pair of ducts, 
1. The Main pancreatic duct  (duct of Whirsung) 
2. Accessory pancreatic duct (duct of Santorini) 
The main pancreatic duct is seen in the posterior part of the pancreas.  It starts at the tail 
and runs towards the head and receiving tributaries at right angles and becoming larger in 
size. It joins the common bile duct to form the Ampulla  of Vater, which opens in the 
duodenum.  
Endocrine Pancreas 
The endocrine part of the gland is formed by collection of cells called the Islets of 
Langerhan‟s found scattered within Pancreatic lobules,in duct epithelium and among the 
acini.The islets are surrounded by acinar cells.  There are about 100,000 islets in the 
pancreas and Each islet contains 1000-3000 cells.Thus altogether there are 100-300 
million(β) cells which can store 200 units of insulin and release 30-50 units of Insulin per 
day. Islet cell tissue is greatly concentrated in the tail and drain their secretions directly into 
the circulation. 
A. Major cell Types: 
1. Beta (β) cells – Comprise about 70% of islet cells and secrete Insulin, the defective 
response (or) deficient synthesis of which causes Diabetes Mellitus. 
2. Alpha (  )   cells: 
Comprise 20 % of islet cells and secrete Glucagon which induces Hyperglycemia.  
3. Delta (  ) Cells : 
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Comprise 5 to 10 % of islet cells and secrete Somatostatin which suppresses both Insulin 
and Glucagon release. 
4. Pancreatic Polypeptide (PP) cells (or) F Cells: 
Comprise 1 to 2 % of islet cells sand secrete Pancreatic Polypeptide having some 
gastrointestinal effects. 
B. Minor Cell Types:   
1. D1 Cells elaborate Vasoactive Intestinal Peptide (VIP), which induces glycogenolysis and 
hyperglycemia and causes secretory diarrhoea by stimulation of gastro intestinal fluid 
secretion. 
2. Enterochromaffin cells - Synthesis Serotonin, which in pancreatic tumours may induce 
Carcinoid syndrome. 
 Physiology of the pancreas 
1. Functions of Exocrine pancreas 
 The main functions of the exocrine pancreas is the alkaline secretion of 
digestive enzymes and proenzymes (zymogens) and prominent among enzymes are trypsin, 
chymotrypsin, aminopeptidases,elastase,Lactase, amylases, lipase and Phospholipase. 
2. Functions of Endocrine Pancreas 
 The endocrine portion of the gland the Islets of Langerhans produces the 
hormones Insulin and Glucagon concerned with regulation of  carbohydrate,protein,fat  
metabolism and blood sugar level. 
INSULIN 
1. Insulin was first isolated from the Pancreas in 1922 by Banting and Best.Insulin is a 
polypeptide containing two chains of amino acids linked by disulfide bridges having 
molecular weight of 5808. 
2. It is synthesized in the endoplasmic reticulum of the β cells as Preproinsulin that give rise to 
Proinsulin which undergoes peptic cleavage to form Insulin and C-peptide. C-peptide 
connects  and β chains. 
3. The half life of insulin in the circulation in humans is about 5 minutes and cleared from 
circulation within 10-15 minutes and stored in beta cell granules and discharged into 
interstitial fluid under appropriate stimulus, enters portal circulation and liver traps 50-60% 
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and remaining enter peripheral circulation.It is degraded by enzyme Insulinase in liver,in 
the kidneys and muscles. 
EFFECTS OF INSULIN: 
Rapid  (Seconds) Increased transport of glucose, amino 
acids and K+ into insulin sensitive cells. 
Intermediate (Minutes) Stimulation of Protein Synthesis 
Inhibition of protein degradation 
Activation of glycogen synthesis and 
glycolytic Enzymes 
Inhibition of Phosphorylase and 
gluconeogenic enzymes. 
Delayed (hour) Increase in mRNA for lipogenic and other 
enzymes. 
  
 The net effect of the hormone is storage of Carbohydrate, Protein, and fat.  
Therefore Insulin is appropriately called the „hormone of abundance‟. Total daily release in 
man is about 50 IU out of a pancreatic store of 200-250 IU of insulin: 
WHO  CLASSIFICATION: 
1. Diabetes Mellitus: 
 (a) Insulin dependent diabetes mellitus – IDDM type I 
 (b) Non insulin dependent diabetes mellitus- NIDDMType II 
  (i)  Obese 
  (ii) Non obese 
 (c) Malnutrition related diabetes mellitus – MRDM. 
 (d) Other types – Secondary 
  Hormonal 
  Drug induced 
  Pancreatic 
  Other abnormalities. 
1. Impaired glucose tolerance – IGT 
2. Gestational diabetes mellitus – GDM 
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CLASSIFICATION OF DIABETES MELLITUS 
I.        Primary Diabetes Mellitus 
Type -  I    Insulin  Dependent Diabetes Mellitus -IDDM 
Type - II    Non-Insulin Dependent Diabetes Mellitus  - NIDDM  
II.      Secondary Diabetes Mellitus 
1. Pancreatic pathology 
a) Pancreatitis 
b) Haemochromatosis 
c) Cystic fibrosis 
d) Neoplastic disease 
e) pancreatectomy 
S. 
No. 
 Type  I Type  II 
1. Age <  30 years >  30 years 
2. Seasonal incidence Present Absent 
3. Autoimmunity To islet cell, insulities, 
other autoimmune 
disease 
Not present 
 
 
4. Heredity HLA – DR3 (or) DR4 > 
90% 
NO HLA Connection 
5. Clinical Markedly emaciated 
classical symptoms are 
present 
Merkedly  obese 
classical symptoms 
usually lacking. 
6. Serum Insulin Less (or) Nil May be less (or) more 
7. Keto acidosis Prone Not so 
8. C-Peptide Disappears Remains 
9. Treatment By insulin Oral hypoglycaemic 
drugs rarely insulin. 
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2. Excess Endogenous production of hormonal antagonists  to Insulin 
a) Growth hormone (Acromegaly) 
b) Glucocorticoids (Cushing‟s Syndrome) 
c) Thyroid  hormone (Hyperthyroidism) 
d) Catecholamines (Pheochromocytoma) 
e) Pregnancy  (Human Placental lactogen – Gestational DM) 
f) Glucagon  (Glucagonoma) 
g) Counter regulatory   
hormones  (Severe burns, trauma) 
3. Iatrogenic 
Cortico Steroids 
Thiazide diuretics 
Phenytoin 
4. Liver diseases 
III. Associated with Genetic syndromes 
i. Lipoatrophy 
ii. Muscular dystrophies 
iii. Friedreich‟s dystrophies 
iv. Down syndrome 
v. Klinefelter‟s syndrome 
vi. Turner‟s Syndrome 
vii. DIDMOAD (ie. Diabetes insipidus, Diabetes mellitus, optic atrophy, Nerve deafness.) 
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PATHOGENESIS: 
 It is a complex affair and is still far from clear, Lack of insulin, presence of 
insulin antagonists, excessive neoglucogenesis, viral infection HLA system, 
heredity, auto immunity jointly (or) in proportion are possibly responsible for the 
development of diabetes. 
 Due to lack of insulin blood sugar level steadily rises and when it crosses 
the renal threshold  level of 180mg/ 100cc glycosuria results.  Renal threshould 
level,  however varies with age and pregnancy.  Glucose increase the osmolarity of 
glomerular fillrate and  this results in profuse diruresis even up to 10 to 15 liters per 
day associated with hyponatraemia, hypokalaemia and hypomagnesaemia. Thus 
intense thirst, dehydration shock and crystalloid imbalance may develop.  
 Again as sugar is not burnt, adequately  for energy requirement, fat is 
mobilized from the adipose tissues and large quantities of free acid circulate in the 
blood.  Normally these are burnt in the liver.  But as these are produced in large 
quantities of acetone which accumulate in the blood and ultimately appear in urine 
and breath. 
 Several hormones particularly the growth hormone may help in this  
process incompletely metabolized carbohydrate Eg. Pyruvic acid and lactic acid also 
accumulate in the blood.  This conditions is called diabetic keto acidosis which  
often leads to coma and death. 
 Liver is enlarged due to fat infiltration and blood contains enormous 
amount of neutral fat and various hormones may act as insulin antagonists.  Apart 
from there, insulin antibodies may be produced in the blood.  Lastly due to 
continuous loss of sugar in the urine the process of neoglucogenesis from protein 
maybe stimulated which may result in wasting of muscles and increased urinary loss 
of nitrogen. 
 
Clinical features 
1. Glucosuria: When blood glucose level is above 180mg/dl,glucose appears in urine. It is the 
renal threshold for glucose. 
2. Osmotic diuresis: The excess glucose in renal tubules decrease reabsorbtion of water result 
in diuresis. This leads to polyuria, polydipsia. 
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3. Polyuria: The amount of urine may be several litres in 24 hours. This is due to excessive 
sugar in the urine which acts as a diuretic. 
4. Polydipsia,dryness of mouth:  Polyuria decreases water content in the body stimulates 
taste centre  and in turn  increases water intake. 
5. Polyphagia and Predilection for sweet food: This symptom is due to non utilization of 
sugar for energy expenditure. 
6. Asthenia: This is due to protein depletion and increased utilization of protein for energy. 
7. Emaciation:It  is due to loss of water, glycogen and triglyceride and protein stores and  
gradually reduced muscle mass occurs. 
8. Pruritis vulvae, Balanitis(genital candidiasis), Skin sepsis(boils): This is due to irritant 
action of sugar on the tissue and fungal (or) bacterial infections 
9. Constipation: The stool becomes hard and bowel movement may take place after every 2 
to 3 days. 
10. Nausea,headache,blurring of vision 
11. Mood change, irritability, difficulty in concentrating, apathy 
12. Unhealed wounds 
13. Frequent changes in refractive error and Cataract 
 
Complications of Diabetes: 
 Virtually every tissue and organ is biochemically and structurally altered as a 
consequence of the hyperglycemia of diabetes.Two biochemical mechanisms appear 
to be involved in the development of many complication.  In the first glucose 
reversibly bind to the body proteins.  This is a non enzymatic event that can cause 
structural and functional abnormalities of the involved proteins.  The concentration 
of glycosylated hemoglobin in the blood is now used clinically as a measure of 
therapeutic control. 
 The second biochemical mechanism operate in the lens of the eye, Kidney and 
peripheral nerves.  These tissues are endowed with an enzyme, aldose reductase, that 
facilitates the accumulation of sorbital and fructose in cells of the hyperglycemic 
patient.  As a result of the intracellular accumulation of sorbital and fructose an 
osmotic gradient is established and excessive amounts of water enter the cells from 
the extra cellular compartment.  The cells then swell and are damaged.  
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ACUTE COMPLICATIONS: 
Hypoglycaemia:  
 Hypoglycaemia, defined as a blood glucose concentration of less the 2.5 
mmol/L, occurs commonly in diabetic patients treated with insulin and infrequently 
in those taking a sulphonylurea drugs.  Severe hypoglycaemia result in severe 
morbidity ie coma, convulsion, brain damage, stroke, myocardial ischaemia, 
vitreous haemorrhage, hypothermia and accidents. 
Symptoms of Hypoglycaemia: 
Sweating, trembling, hunger, anxiety, confusion, drowsiness, speech difficulty, 
nausea, tiredness and headache. 
 
DIABETIC KETOACIDOSIS: 
   As a result of polyuria there will be dehydration, hyponatremia and 
hypopotassemia.  The intra cellular water comes out in the extra cellular space as a 
result of hyperosmolarity of the extracellular fluid due to increase of glucose. 
Plasma volume is decreased, blood pressure falls and renal blood flow is diminished 
resulting in oliguria.  The cellular glycogens and protein are catabolised. 
   Sugar is not burnt, fat is metablised from the adipose tissues and large 
quantities of free fatty acid circulate in the blood.  Normally these are burnt in the 
liver, into carbondioxide and water.  But as these free fatty acid are produced in 
large quantities.Acetyl to enzyme – A – accumulates and after condensation forms 
acetoacetic acid and its derivatives beta hydroxybutyric acid and acetone, which 
accumulate in the blood and ultimately appear in urine and breath.  Incompletely 
metabolised carbohydrate.  Eg pyruvic acid and lactic acid also accumulate in the 
blood.  This conditions is called diabetic ketoacidosis. 
   When ketone bodies accumulate the cells are further dehydrated ultimately 
ph of the blood falls.  This acidosis stimulates the respiratory centre where by 
pulmonary ventilation is increased giving rise to air hunger.  The breath contains the 
smell of acetone which is very diagnostic of this condition.  The  function of the 
brain cell is depressed and gradually coma supervenes. 
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The cardinal biochemical features of diabetic ketoacidosis are : 
 Hyper glycaemia 
 Hyperketonaemia 
 Metabolic Acidosis 
Diabetes and the eye 
Cataract 
 The cataract is a clouding of the lens of the eye. Which causes the vision to become 
blurred or dim because light control pass through the clouded lens to the back of the eye. 
There is a very common eye condition that develops as people get older but some one with 
diabetes may develop cataract at an earlier age than someone without diabetes. 
Diabetic Retinopathy 
 Diabetic retinopathy is the most common cause of blindness in adults between 30 and 
65 years of age  in developed countries. 
Clinical features of Diabetic Retinopathy 
Micro aneurysms 
Haemorrhages 
Hard exudates 
Soft exudates 
Intra retinal microvascular abnormalities 
Neovascularisation 
Venous Changes 
Fibrosis 
Diabetic Neuropathy 
This is a relatively early and common complication affecting approximately 30% of diabetic 
patients. Although in a few patients it can cause severe disability it is symptomless in the 
majority. 
Clinical Features 
Symmetrical sensory polyneuropathy 
Asymmetrical motor diabetic neuropathy 
Mononeuropathy 
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Autonomic neuropathy 
Diabetic neuropathy usually progresses through  several stages. 
 
Diabetic foot 
 The foot is a frequent site for complications in patients with diabetes and for this 
reason foot care is particularly important. 
 
Clinical features of Diabetic foot 
 Neuropathy    Ischaemia 
 Symptoms 
 Paraesthesiae                           *     Claudication 
 Pain     *      Rest pain 
 Numbness     
  
A GUIDE TO FOOT CARE
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Do's 
 Inspecting one's own feet daily or have someone else to inspect them for any breaks in the 
skin, blisters, calluses or corns. 
 Washing feet daily in luke warm water. To avoid extremes of temperature and always 
checking the temperature of the water before using it. 
 Using moisturising cream for dry fissured skin and apply powder, especially between the 
toes, if the skin is prone to moistness. 
 To have feet measured carefully when purchasing shoes and to buy lace-up shoes with 
plenty of toe room. 
 Inspecting the shoes before wearing them, both inside and outside for foreign objects. 
 Keeping feet away from heaters, hot water bottles and other hot objects. 
 The feet should  be  checked everytime while visiting the Clinic. 
Dont's 
 Not to use tobacco in any form 
 Avoiding unaccustomed lengthy walks, for example, when on holiday. 
 Not to cut nails very close to the edge and not to have sharp edges. 
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 Should not try to be one's own doctor, since corns and calluses have to be treated with 
professional help only. 
 Not to use over-the-counter (OTC) Medicines. Rather to consult doctor. 
 Not to walk barefoot, even at home 
 Avoiding ill fitting shoes. 
 Not to wear socks with tight elastic, soft corns socks are best. 
 Avoiding hard-sole footwear 
 Not to wear shoes with dividers between the toes. 
DIETARY MANAGEMENT 
General Principles 
Proportion of Energy 
Energy Recommended Diet 
Carbohydrate 50 - 55% 
Fat 30 - 35% 
Proteins 10 - 15% 
Types of Diabetic Diet 
Two basic types of diet are used in the treatment of diabetes: 
Low-energy weight - Reducing Diet 
Weight Maintenance Diet 
 
Management of Diabetes mellitus 
 The aim of treatment is to achieve normal blood glucose levels,to alleviate 
symptoms and to prevent complications. 
The four pillars of Diabetic management are, 
1. Diet 
2. Exercise 
3. Drugs –Oral hypoglycaemic agents and Insulin therapy by regular monitoring of glycaemic 
control. 
4. Early detection and treatment of complications. 
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A. DietIt is the cornerstone of management of Diabetes.The objective is to have good 
glycaemic control and to provide a nutritious and balanced diet. In type 2 diabetes the 
calories need to be restricted in order to avoid obesity. 
B. Total caloric intake: 
It depends on body weight,degree of physical activity and presence of comorbid illness. 
        
Body mass index: It determines the total caloric requirement 
BMI= Weight(in kg) / Height in m
2
.      
BMI Normal range:  22- 25. 
  The calories are derived from three principal sources like 
Carbohydrates,Proteins and Fats. 
Carbohydrates 
  The amount of carbohydrate recommended in the diet is upto 50-60%. Whole 
grains, Ragi, Wheat, Millets, Oats, Brown rice which have low glycaemic index are 
recommended. 
Proteins 
  Recommended amount is12-20% of total calorie intake.  Dhals or Grams with 
outer skin and Sprouts,lean meat ,fish, egg white and chicken are preferred.   
Salt - Dietary salt should be less than 6g/day. 
Fat 
  It should be 20-24% of total intake. Sunfloweroil, Gingely oil,Safflower 
oil,Oive oil rich in Mono and Polyunsaturated fats are advised. Palmoil, Coconut oil and 
Vanaspathi should be avoided. 
Milk and milk products:        
 Contribute to 40-45% of total fat content of vegetarian diet. Skimmed milk 
Unsweetened Yogurt, Curd, Buttermilk are recommended. 
Vegetables: Fibre rich greens, brinjal, cauliflower, gourds and salads are advised.  
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Diet Plan for Diabetes          
Time Regime 
Morning 6.00 Coffe/tea/ skimmed milk without sugar 1 
cup 
Morning 8.30 Idli-2/dosa-2/chapatti-2/pongal 1 cup 
Morning 11.00 Vegetable soup/lemon juice/buttermilk 1 
cup/ any fruit 
Afternoon 1.00 Rice-2 cups/chapatti-3/dhal/watery 
vegetables Chicken/fish/butter milk 
Evening 4.00 Moong dal/Channadal/coffee/tea 
Evening 6.00 any fruit 
Night Idli-2/chapathi-2/rice-1 cup 
Before bedtime Milk 1 cup without sugar 
            
Physical activity 
Exercise forms an important component along with drugs and diet management in 
type 2 DM.Patients should be encouraged to take regular physical activity in form of 
Walking, Jogging, Swimming, Gardening and Cycling for 30 minutes daily. This improves 
Insulin sensitivity, prevents complications of Diabetes, and assist in maintaining Lipid 
profile and Bloodpressure, improves muscle strength and beneficial for mental state of 
individual. 
 
 
 
 
48 
 
 
 
 
TRIAL DRUG 
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TRIAL DRUG 
PREPARATION  OF TRIAL MEDICINE 
 Drug Name :Naval kottai chooranam 
Text reference: 
Aringar Anna Government Hospital of Indian Medicine Pharmacopeia ( pgno. 11)
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Preparation of Naval kottai Chooranam: 
Ingredients : 
 Syzygium  cumini  
 Emblica officinalis  
 Cassia fistula  
 Gymnema sylvestre  
 Cassia auriculata  
 Curcuma longa  
 Cyperus rotundus  
 Terminalia chebula  
Procedure : 
The herbs present in naval kottai chooranam are shade dried and powdered. 
Dosage    : 1 – 2 gm/ bd 
Adjuant   : Water 
Duration : 90 Days  
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LITERATURE REVIEW OF TRIAL MEDICINE 
Naval  kottaiChooranam 
 Botanical name :Cyperus rotundus  
Suvai: thuvarppu 
Thanmai: thatpam  
Pirivu: inippu 
அெிசோ஭ம்பித்ெம்அனற்மோகம்ஐ஬ங்  
குெிலோெஞ்நசோபங்தகோடி஬-முெிர்லோந்ெி59 
 Botanical name :Emblica officinale  
Suvai: thuvarppu, inippu,pulippu 
Thanmai: thatpam 
Pirivu: inippu 
஑டு஫ிவெச்சித்ெத்ெில்உன்னஅனலுடநன  
கூடுபிமந஫கமும்நபோங்கூறு60. 
 Daily intake of Emblica officinale juice with fresh bitter gourd juice will stimulate the 
pancreas to secrete insulin
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 Botanical name : Gymnema sylvestre  
Suvai: kaipu  
Thanmai: veppam  
Pirivu: karpu 
அக்க஭ங்கள்ெீர்க்கும்அதுசு஭ந்ெோகந்தெோவயக்குந்  
ெக்கசிறுகுமிஞ்சோந்ெோன்62 
 Water extract of gymnema sylvestre leaf tested in alloxan induced rat showed reduction in 
blood glucose level
63
.   
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 Botanical name : Terminalia chebula  
Suvai: thuvarppu 
Thanmai: thatpam 
Pirivu: inippu 
 It is  Glucosidase inhibitor- Retard the liberation of D-Glucose from dietary complex and 
delay glucose absorption.  
 Botanical name : Syzygium cumini  
Suvai: thuvarppu 
Thanmai: thatpam 
Pirivu: karppu  
஫ோந்ெம்லிவரயும்லயிக஭ப்போனுண்டோகும்  
நசர்ந்ெதெோரு ீரிறிவுஞ்நசருந஫ோ64 
 4g/kg dose level found to exhibit maximum hypoglycemic effect in rabbits,3 hrs after 
medication.
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 Botanical name : Cassia auriculata  
Suvai: thuvarppu 
Thanmai: thatpam 
Pirivu: inippu 
ந஫ோகத்ெினோநயலிவரந்ெசயம்தலட்வட஬னல்  
ஆகத்ெின்ன௃ண்நணோடருங்கி஭ோணி-நபோகத்ெோன் 
ஆலவ஭பஞ்சங்தகோள்அத்ெிசு஭ம்ெோகமும்நபோம்  
ஏலோவ஭க்கண்ட஫ட஫ோநெ!66 
Antidiabetic activity of various extracts of cassia auriculata on alloxan induced 
diabetic rats has potent anti diabetic and anti oxidant property.  
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 Botanical name : Cassia fistula  
Suvai: thuvarppu 
Thanmai: veppam  
Pirivu: karppu 
Aqueous extract of Cassia fistula  increases insulin secretion and reduce blood 
glucose levels in Streptozotocin induced diabetic rats
67
.  
 Botanical name : Curcuma longa  
Suvai: karppu, kaipu 
Thanmai: veppam  
Pirivu: karppu 
ெவயலயி ீந஭஭ற்மஞ்சவர஬ோெந஫கம் 
உவயவுெருபனீிசத்ெினூநட68 
Aqueous extract of Curcuma longa increases insulin secretion and reduce blood 
glucose levels in Streptozotocin induced diabetic rat .
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TRIAL DRUG-NAVAL KOTTAI CHOORANAM 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
NAVAL KOTTAI KONDRAI POO 
KADUKAI THOL SIRU KURINJAN ILAI 
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AAVARAM POO 
MANJAL KIZHANGU 
NELLI VATRAL KORAI KIZHANGU 
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MATERIALS AND METHODS 
Introduction 
The clinical trial for Madhumegam(Diabetes Mellitus) was decided to be 
conduct as an open label study. 
 
Study place 
The entire study was conducted on patients attending OPD of Govt Siddha 
Medical College,Chennai attached to Arignar Anna govt hospital for Indian medicine,   
Arumbakkam,Chennai-106, during the period of 2014-2016. 
Data collection:Literary evidence from various, 
 Siddha books 
 Modern books 
 Medical journals 
 Internet 
Population: 
The Population consists of Diabetes accompanied by Polyuria Polyphagia,Polydipsia, 
generalised tiredness,Fatigue,Peripheral neuritis, Itching all over the body and satisfying the 
inclusion and exclusion criteria mentioned below. 
Sample size: 40 patients.         
 
Inclusion criteria: 
1. Subjects within 3rd to 6th decade. 
2. Non-Insulin dependent diabetes mellitus 
3. Polyuria, polyphagia, polydipsia, nocturia 
4. Noticeable weight loss 
5. Fatigue, lethargy, tiredness 
6. Peripheral neuritis, 
7. Pruritis all over the body 
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Criteria for Exclusion(based on clinical history) 
1. History of Insulin dependent diabetes mellitus 
2. History of Secondary diabetes 
3. History of Cardiovascular diseases 
4. History of Diabetic nephropathy 
5. History of Diabetic retinopathy 
6. Vulnerable population such as Pregnant women,Lactatingmothers,TB affected 
individuals, HIV positive (Clinical History) 
 
Duration of treatment: 90 days 
Patients were followed under the guidance and supervision of the HOD, 
Professor,Reader,Lecturer and Asst.Lecturer of the Pothu Maruthuvam, P.G.Department, 
GSMC, Chennai-106. 
The patients were carefully studied for their history, clinical examinations, 
investigations and management. 
Evaluation of Clinical Parameters 
The history includes past, personal, family, occupation, dietary habits and associated 
history.  
 
Clinical Investigations: 
Blood 
TC (cells/cu mm)                                  Blood urea 
DC (%)                                                 Serum cholesterol 
ESR (mm) 
Hb (gms%) 
Sugar (Random, Fasting, Postprandial) 
HbA1C  
Urine 
Albumin 
Sugar 
Deposits 
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Siddha Assessments: 
Envagaithervugal 
Neerkuri 
Neikkuri 
A case sheet format was prepared based on the Siddha methodology example 
Envagaithervugal, Mukkutram, Nilam, Kaalam, Udalthathukkal including Neerkuri 
and Neikuri. Individual case sheet was maintained for each patient at outpatient 
department. 
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RESULTS AND OBSERVATIONS 
The study on Madhumegam was carried out in 40 patients in the  Outpatient 
department PG of Pothu Maruthuvam,Govt Siddha Medical College attached to Arignar 
Anna  Govt hospital for Indian medicine,Chennai-106, during the period 2012-2014 were 
analysed.The observation were made and tabulated with following criteria. 
1. Age distribution 
2. Sex distribution 
3. Occupational status 
4. Socio economic status 
5. Dietary habits 
6. Family history 
7. Kaalam 
8. Paruva Kaalam 
9. Thinai 
10. Duration of illness 
11. Mukkutram 
a. Vali 
b. Azhal 
c. Iyam 
12. Ezhu udalthathukkal 
13. Ennvagai thervugal 
14. Naadi 
15. Neikuri 
16. Clinical features 
17. Clinical prognosis 
18. Urine sugar 
a. Fasting, b.Postprandial 
19. Blood sugar 
a. Fasting, b.Post prandial 
20. HbA1C Level 
            21.Grading of results 
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1. AGE DISTRIBUTION 
S. No Age groups No. Of cases Percentage (%) 
1. 30- 40 years 6 15% 
2. 41- 50 years 18 45% 
3. 51- 60 years 15 37.5% 
4. 61- 70 years 1 2.5% 
 
 
Inference: 
From Selected 40 cases,6 patients (15%) were between 30-40yrs, 18 patients 
(45%) were between 41-50, 15 patients (37.5%) were between 51-60, 1 patient (2.5%) 
were between 61-70 yrs. 
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2. SEX DISTRIBUTION 
S. No. Sex No. Of cases Percentage (%) 
1 Male 23 57.5% 
2 Female 17 42.5% 
 
 
Inference: 
Out of 40 patients, 17 cases (42.5%) were female and 23 cases (57.5%) were 
male. 
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3. OCCUPATIONAL STATUS 
OCCUPATION NO. OF CASES PERCENTAGE 
House wife 7 17.5% 
Business 8 20% 
Office going 18 45% 
Labour 7 17.5% 
 
 
Inference: 
Out of 40 patients, 7 patients (17.5%) were housewife, 8 patients (20%) were 
doing business , 18 patients (45%) were  office goers, 7 patients (17.5%) were labourers. 
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4. SOCIO-ECONMIC STATUS 
S. No Socio-economic status/Month No. of cases Percentage (%) 
1. Poor ( below 20,000) 13 32.5% 
2. Middle class (20,000- 50,000) 20 50% 
3. High status ( Above 50,000) 7 17.5% 
 
 
Inference: 
Regarding socio-economic status, 13 patients (32.5%) comes under poor 
category, 20 patients (50%) comes under middle class category, and 7 patients (17.5%) 
comes under high class category. 
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5. DIETARY HABITS       
     
DIETARY HABITS NO. OF CASES PERCENTAGE  
Vegetarian 8 20% 
Mixed 32 80% 
 
 
Inference: 
Regarding Diet, out of 40 patients, 8 patients (20 %) take vegetarian diet and 32 
patients(80%) takes mixed diet. 
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6. FAMILY HISTORY 
FAMILY HISTORY  NO. OF CASES PERCENTAGE % 
Father 6 15% 
Mother  6 15% 
No Relevant History 28 70% 
 
 
Inference: 
Regarding Family history, 6 patient‟s(15%) father was  diabetic, 6 patient‟s 
(15%) mother was diabetic and 28 patients (70%) had no family history of Diabetes. 
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7. DISTRIBUTION OF KAALAM 
KALAM NO. OF CASES PERCENTAGE 
Vatha Kaalam 
0- 33 years 
2 5% 
Pitha Kaalam 
34-66 years 
 
37 92.5% 
Kaba Kaalam 
67-100 years 
 
1 2.5% 
 
 
Inference: 
Out of 40 patients, 2 patients (5%) comes under Vatha kaalam, 37 patients 
(92.5%) comes under Pitha kaalam, and 1 patient (2.5%) comes under Kaba kaalam. 
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8.PARUVAKAALAM 
S.No Paruvakaalam 
(Seasons) 
Month No.of 
cases 
Percentage(%) 
1. Kaarkaalam Avani,Puratasi(Mid Aug-
Mid Oct) 
3 7.5% 
2. Koothirkaalam Iyppasi,Karthigai (Mid 
Oct-Mid Dec) 
2 5% 
3. Munpani Margazhi,Thai (Mid 
Dec-Mid Feb) 
21 52.5% 
4. Pinpani Maasi,Panguni  (Mid 
Feb-Mid April) 
6 15% 
5. Elavenil Chithirai,Vaigasi 
(Mid April-Mid June) 
4 10% 
6. Mudhuvenil Aani,Aadi  (Mid June-
Mid Aug) 
4 10% 
 
 
Inference: 
From selected 40 patients, 3 patients (7.5%) comes under Kaarkaalam, 2 patients 
(2.5%) comes under Koothir kaalam, 21 patient (52.5%) comes under Munpani, 6 
Patients (15%) comes under Pinpani,4 patients comes under Elavenil and 4 patients 
comes under Mudhuvenil . 
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9. DISTRIBUTION  OF  THINAI    
        
THINAI NO. OF CASES PERCENTAGE 
Kurinji 0 0 
Mullai 0 0 
Marutham 4 10% 
Neithal 36 90% 
Paalai 0 0 
 
 
Inference: 
Out of 40 patients, 4 patients (10%) comes under Marutham, 36 patients (90%) 
comes under Neithal nilam. 
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10. DURATION OF ILLNESS 
S. No Duration of illness No. of cases Percentage (%) 
1. Newly identified 10 25% 
2. 3-6 months 16 40% 
3. 6 months to one year 7 17.5% 
4. More than one year 7 17.5% 
 
 
Inference: 
Out of 40 patients,10  patients (25%) belongs to newly identified  category, and 
16 patients (40%) belongs to 3-6 months category, 7 patients (17.5%) belongs to 6 
months to one year category, 7 patients (17.5%) belongs to more than one year category. 
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11.REFERENCE TO MUKKUTRAM 
a. Affected vali: 
S. No Classification of Vali No. of cases Percentage (%) 
1. Pranan 0 0% 
2. Abanan 40 100% 
3. Viyanan 40 100% 
4. Udhanan 0 0% 
5. Samanan 40 100% 
6. Naagan 0 0% 
7. Koorman 6 15% 
8. Kirugaran 40 100% 
9. Devathathan 40 100% 
10. Dhananjayan 0 - 
 
 
Inference: 
 From the Selected 40 patients, Abanan was affected in 40 patients (100%), 
Viyanan was affected in 40 patients (100%), Samanan in 40 patients (100%), Koorman 
in 6 patients (15%), Kirugaran in 40 patients (100%), Devathathan in 40 patients (100%). 
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b. Affected azhal 
S. No Classification of Azhal No. of cases Percentage (%) 
1. Analagam 40 100% 
2. Ranjagam 8 20% 
3. Saathagam 40 100% 
4. Aalosagam 6 15% 
5. Prasagam 4 10% 
 
 
Inference: 
Out of 40 patients Analagam and Sathagam affected in all patients (100%), 
Ranjagam  affected in 8 patients (20%), Aalosagam was affected in 6 patients (15%) and 
Prasagam was affected in 4 patients(10%). 
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c. Affected iyyam 
S. No Classification of Iyyam No. of cases Percentage (%) 
1. Avalambagam 0 0% 
2. Klethagam 40 100% 
3. Pothagam 0 0% 
4. Tharpagam 0 0% 
5. Santhigam 26 65% 
 
 
Inference: 
Out of 40 patients, Kilethagam was affected in 40 patients (100%), Santhigam 
was affected in 26 patients (65%). 
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12. EZHU UDAL THATHUKKAL 
S. No Ezhu udal thathukkal No. of cases Percentage (%) 
1. Saaram 40 100% 
2. Senneer 40 100% 
3. Oon 4 10% 
4. Kozhuppu 4 10% 
5. Enbu 28 70% 
6. Moolai 0 0% 
7. Sukkilam/Suronitham 0 0% 
 
 
Inference: 
From the above chart we can observe that Saram and Senner were affected in all 
patients ie.100%. Oon, Kozhuppu affected to the extent of 10% and 10% respectively 
and enbu affected in 28 patients( 70%). 
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13. ENVAGAI THERVUGAL 
S. No Envagai Thervugal No. Of cases Percentage (%) 
1. Naa 40 100% 
2. Niram 5 12.5% 
3. Mozhi 0 0% 
4. Vizhi 6 15% 
5. Sparisam 6 15% 
6. Malam 8 20% 
7. Moothiram 40 100% 
8. Naadi 40 100% 
 
 
Inference: 
Regarding Envagai thervu, Naa was affected in 40 patients (100%), Niram was affected 
in 5 patients (12.5%),Vizhi was affected in 6 patients (15%),Sparisam affected in 6 
patients(15%) and Malam was affected in 8 patients (20%) and Moothiram in 40 
patients(100%), Naadi affected in 40 patients(100%). 
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14. NAADI 
S. No Naadi No. Of cases Percentage (%) 
1. Pitha vatham 26 65% 
2. Vatha pitham 8 20% 
3. Pitha kabam 6 15% 
 
 
 
Inference: 
26 patients(70%) had PithaVatha Naadi and 8 patients(20%) had Vatha Pitha 
naadi and 6 patients(15%) had Pitha kaba  naadi. 
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15. NEIKURI REFERENCE 
S. No Neikuri Character of urine No. of cases Percentage (%) 
1. Vatha neer Spreads like snake 10 25% 
2. Pitha neer Spreads like ring 20 50% 
3. Kabha neer Float like pearl 10 25% 
 
 
Inference: 
10 patients (25%) had vatha neer, 20 patients (50%) had Pitha neer,10 patients 
(25%) had Kabha neer. 
 
 
 
 
 
 
 
 
25%
50.00%
25.00%
NEIKURI
Vatha neer
Pitha neer
kaba neer
79 
 
 
16. CLINICAL FEATURES 
S. No Signs& Symptoms No. of cases Percentage (%) 
1. Polyuria 40 100% 
2. Polyphagia 40 100% 
3. Polydipsia 40 100% 
4. Pruritis vulvae/Balanitis 4 10% 
5. Itching all over the body 10 25% 
6. Pain all over the body 34 85% 
7. Dryness of mouth and throat 40 100% 
8. Constipation 8 20% 
9. Emaciation 4 10% 
10. Peripheral neuritis 10 25% 
11. Diabetic foot ulcer 0 0% 
12. Cataract/Diabetic retinopathy 0 0% 
13. Disturbed sleep 40 100% 
 
 
Inference: 
In respect of the patients with Madhumegam the clinical symptoms of Polyuria, 
Polyphagia, Polydipsia, dryness of the mouth and throat and disturbed sleep were present 
in all cases i.e 100%.Pruritis vulvae present in 4 cases(10%),Itching all over the body in  
10patients(25%),Pain all over the body in 34cases(85%),Constipation in 8 patients 
(20%),emaciation in 4 cases(10%) and Peripheral neuritis in 10 cases (25%). 
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17. CLINICAL PROGNOSIS 
S. No Signs&Symptoms Before Treatment After Treatment 
No. of 
cases 
Percentage 
(%) 
No. of 
cases 
Percentage 
(%) 
1. Polyuria 40 100% 7 17.5% 
2. Polyphagia 40 100% 5 12.5% 
3. Polydipsia 40 100% 4 10% 
4. Pruritis vulvae 4 10% 0 0% 
5. Itching all over the body 10 25% 0 0% 
6. Pain all over the body 34 85% 7 17.5% 
7. Dryness of mouth and throat 40 100% 0 0% 
8. Constipation 8 20% 0 0% 
9. Emaciation 4 10% 3 7.5% 
10. Peripheral neuritis 10 25% 4 10% 
11. Disturbed sleep 40 100% 4 10% 
 
 
Inference: 
The clinical signs and symptoms were improved after treatment showing only 
17.5% of the people have poly urea, 12.5% of the people have polyphagia,10% of the 
people have polydipsia , 17.5%  had pain all over the body, 10% have peripheral neuritis 
and 10% have disturbed sleep. The symptoms of Pruritis vulvae,itching all over the 
body,dryness of mouth and constipation were completely relieved. 
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18.(A) URINE SUGAR - FASTING 
URINE 
SUGAR 
BEFORE 
TREATMENT  
 
PERCENTAGE % AFTER 
TREATMENT  
PERCENTAGE% 
++ 10 25% 0   0% 
+ 18 45% 7 17.5% 
NIL 12 30% 33 82.5% 
 
 
Inference: 
From the above chart it may be observed that the Urine sugar position on fasting 
after treatment had improved drastically,and it was nil in 82.5% of the cases after 
treatment. 
 
 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
2+
1+
NIL
25%
45.00%
30.00%
0%
17.50%
82.50%
URINE SUGAR- FASTING
Before treatment
After treatment
82 
 
(B)URINE SUGAR – POST PRANDIAL 
URINE 
SUGAR 
BEFORE 
TREATMENT  
 
PERCENTAGE % AFTER 
TREATMENT  
PERCENTAGE% 
+++ 14 35% 0 0% 
++ 16 40% 4 10% 
+ 7 17.5% 6 15% 
NIL 3 7.5% 30 75% 
 
 
Inference: 
It may be noted that the Post prandial urine sugar position after treatment had improved 
drastically it was nil in 75% of the cases after treatment. 
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19.(A) BLOOD SUGAR - FASTING 
BLOOD SUGAR 
FASTING (mg) 
BEFORE 
TREATMENT 
NO.OF CASES 
PERCENTAGE % 
AFTER 
TREATMENT NO.OF 
CASES 
PERCENTAGE% 
60 – 109 4 10% 25 62.5% 
110 – 129 7 17.5% 12 30% 
130-149 12 30% 2 5% 
Above 150 17 42.5% 1 2.5% 
 
 
Inference: 
Fasting blood sugar has control in 62.5% of the cases. 
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(B)BLOOD SUGAR POST PRANDIAL 
BLOOD SUGAR 
POST PRANDIAL 
(mg) 
BEFORE 
TREATMENT 
NO. OF CASES 
PERCENTAGE % 
AFTER 
TREATMENT 
NO.OF CASES 
PERCENTAGE% 
100 – 149 1 2.5% 19 47.5% 
150 - 199 14 35% 18 45% 
200 – 249 8 20% 3 7.5% 
250 – above  17 42.5% 0 0% 
 
 
Inference: 
The blood sugar Post prandial level has control in 70% of the cases. 
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20.HBA1C  LEVEL 
HBA1C 
Before treatment  
no. of cases 
Percentage % 
After treatment 
no.of cases 
Percentage% 
Good control       
5.7-6.9% 
9 22.5% 22 55% 
Fair control      
7-8% 
5 12.5% 14 35% 
Poor control 
>8.1% 
26 65% 4 10% 
 
 
Inference: 
HbA1C level has good control in 55% of patients, fair control in 35% of patients 
and poor control in 10% of patients. 
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21.(A) BASED ON FASTING 
S.no Blood Sugar level 
Fasting 
Prognosis No.of 
Patients 
Percentage 
    
1 40-30mg Good 27 67.5% 
2 29-20mg Moderate 6 15% 
3 <20mg Mild 7 17.5% 
 
 
Inference: 
 Of the 40 patients, 27patients(67.5%) showed good result,6 patients (15%)showed 
moderate result and 7 patients(17.5%) showed mild result. 
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(B) BASED ON POST PRANDIAL 
S.no Blood Sugar level 
Post prandial 
Prognosis No.of Patients Percentage 
    
1 51-100mg Good 29 72.5% 
2 30-50mg Moderate 7 17.5% 
3 <30mg Mild 4 10% 
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BLOOD SUGAR LEVEL 
S.No Name Age/Sex Blood Sugar Level 
Before treatment After treatment 
F PP F PP 
1. Babu 57/M 166 262 116 240 
2 Paramanantham 59/M 95 276 95 180 
3 Kuppammal 58/F 162  258 114       182 
4 Elumalai 42/M 139 299 96 140 
5 Selva kumar 54/M 136 280 105 140 
6 Kasturi 67/F 127 172 95 130 
7 Renuga devi 42/F 163 298 109 138 
8 Mohanam 55/M 168 242 110 160 
9 Mabubasha 52/M 199 289 180 249 
10 Anandhi 44/F 139 199 90 142 
11 jagadesh 36/M 151 187 110 140 
12 Subathra 50/F 158 256 110 176 
13 Regina mary 58/F 190 272 140 191 
14 suresh 49/M 136 190 96 126 
15 Mahalakshmi 41/F 136 190 98 142 
16 Manjula 40/F 152 241 102 162 
17 Rajendran 39/M 189 289 100 180 
18 Malliga 50/F 109 142 80 120 
19 Sasikala 45/F 104 213 90 150 
20 Kannan 37/M 126 212 94 138 
21 Sujatha 46/F 181 288 98 142 
22 Shanmugam 53/M 96 168 80 140 
23 Sibu 45/M 117 170 100 120 
24 Ganesan 43/M 120 180 105 150 
25 Shanmugapriya 36/F 157 263 110 160 
26 Babu 48/M 110 160 100 130 
27 Harikrishnan 42/M 139 181 109 130 
28 Siva 46/M 168 299 140 180 
29 Angamuthu 44/M 140 256 110 160 
30 Gowri shankar 39/M 120 168 90 142 
31 Saroja 55/F 133 249 100 160 
32 Kumar 53/M 162 258 120 160 
33 Vasantha 46/F 198 311 120 200 
34 Chandran 49/M 131 169 97 131 
35 Kalalakshmi 52/F 140 210 100 160 
36 Rajagopal 56/M 170 200 120 150 
37 Prabakaran 47/M 158 195 108 160 
38 Thilagavathi 58/F 142 194 110 140 
39 Selvi 60/F 128 278 84 132 
40 Yuvaprasad 53/M 130 210 110 160 
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BMI CHART OF THE PATIENTS 
Sl.no Name Age/Sex Weight (kg) Height (m) BMI Normal/Lean/Overw
eight 
1 Babu 57/M 62 1.62 22 N 
2 Paramanantham 59/M 58 1.60 23 N 
3 Kuppammal 58/F 60 1.63 23 N 
4 Elumalai 42/M 70 1.65 26 O 
5 Selva kumar 54/M 59 1.58 23 N 
6 Kasturi 67/F 59 1.63 22 N 
7 Renuga devi 42/F 68 1.73 22 N 
8 Mohanam 55/M 62 1.60 24 N 
9 Mabubasha 52/M 65 1.70 22 N 
10 Anandhi 44/F 63 1.63 24 N 
11 jagadesh 36/M 50 1.64 18 L 
12 Subathra 50/F 80 1.75 26 O 
13 Regina mary 58/F 70 1.63 26 O 
14 suresh 49/M 70 1.89 24 N 
15 Mahalakshmi 41/F 65 1.63 24 N 
16 Manjula 40/F 60 1.62 22 N 
17 Rajendran 39/M 70 1.70 24 N 
18 Malliga 50/F 75 1.70 26 O 
19 Sasikala 45/F 56 1.57 22 N 
20 Kannan 37/M 61 1.65 22 N 
21 Sujatha 46/F 63 1.63 24 N 
22 Shanmugam 53/M 55 1.55 22 N 
23 Sibu 45/M 70 1.70 24 N 
24 Ganesan 43/M 50 1.63 18 L 
25 Shanmugapriya 36/F 56 1.57 22 N 
26 Babu 48/M 61 1.65 22 N 
27 Harikrishnan 42/M 58 1.63 22 N 
28 Siva 46/M 75 1.70 27 O 
29 Angamuthu 44/M 50 1.63 18 L 
30 Gowri shankar 39/M 61 1.65 21 N 
31 Saroja 55/F 59 1.63 22 N 
32 Kumar 53/M 55 1.55 22 N 
33 Vasantha 46/F 72 1.70 24 N 
34 Chandran 49/M 50 1.63 18 L 
35 Kalalakshmi 52/F 61 1.68 21 N 
36 Rajagopal 56/M 50 1.63 18 L 
37 Prabakaran 47/M 70 1.65 26 O 
38 Thilagavathi 58/F 62 1.65 24 N 
39 Selvi 60/F 61 1.65 21 N 
40 Yuvaprasad 53/M 59 1.63 22 N 
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BIOCHEMICAL ANALYSIS REPORT OF THE PATIENTS 
 
SN 
NO 
O.P NO Name Age / 
Sex 
Blood sugar (mg) Urine sugar HbA1C 
BT AT BT AT BT AT 
F PP F PP F PP F PP 
    
1 4846 Babu 57/M 166 262 116 240 ++ +++ + ++ 8.9 7.8 
2 7150 Paramanantham 59/M 95 276 95 180 NIL +++ NIL + 11.2 7.2 
3 3479 Kuppammal 58/F 162  258 114 182 + ++ + + 8.3 6.9 
4 435 Elumalai 42/M 139 299 96 140 + +++ NIL NIL 9.6 6.2 
5 3234 Selva kumar 54/M 136 280 105 140 + +++ NIL NIL 9.5 6.4 
6 9440 Kasturi 67/F 127 172 95 130 NIL NIL NIL NIL 6 5.8 
7 6020 Renuga devi 42/F 163 298 109 138 ++ +++ NIL NIL 10.2 8.2 
8 7157 Mohanam 55/M 168 242 110 160 ++ ++ NIL + 10.4 8.1 
9 2010 Mabubasha 52/M 199 289 180 249 ++ +++ + ++ 11.6 8.8 
10 8963 Anandhi 44/F 139 199 90 142 + ++ NIL NIL 8 6.5 
11 3583 jagadesh 36/M 151 187 110 140 + ++ NIL NIL 7.7 6.2 
12 402 Subathra 50/F 158 256 110 176 + ++ NIL    + 9.1 7.6 
13 2536 Regina mary 58/F 190 272 140 191 ++ +++ + ++ 11.2 7.8 
14 2443 suresh 49/M 136 190 96 126 + ++ NIL NIL 8.3 6.9 
15 7432 Mahalakshmi 41/F 136 190 98 142    + ++ NIL NIL 6.9 6.1 
16 3565 Manjula 40/F 152 241 102 162 + ++ NIL NIL 9.2 7.1 
17 5471 Rajendran 39/M 189 289 100 180 ++ +++ NIL + 11 7.3 
18 7899 Malliga 50/F 109 142 80 120 NIL + NIL NIL 6.5 6.1 
19 5045 Sasikala 45/F 104 213 90 150 NIL ++ NIL NIL 6.69 6.20 
20 3169 Kannan 37/M 126 212 94 138 NIL ++ NIL NIL 9.5 4.9 
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Sl.No O.P NO Name Age / Sex Blood sugar (mg) Urine sugar HbA1C 
BT AT BT AT BT AT 
F PP F PP F PP F PP 
    
21 3368 Sujatha 46/F 181 288 98 142 ++ +++ NIL NIL 9.8 7.1 
22 49 Shanmugam 53/M 96 168 80 140 NIL + NIL NIL 6.4 6.1 
23 8738 Sibu 45/M 117 170 100 120 NIL NIL NIL NIL 6.7 6.2 
24 9398 Ganesan 43/M 120 180 105 150 NIL + NIL NIL 6.5 6.1 
25 9946 Shanmugapriya 36/F 157 263 110 160 + +++ NIL NIL 8.21 6.2 
26 307 Babu 48/M 110 160 100 130 NIL NIL NIL NIL 6.7 6.1 
27 4905 Harikrishnan 42/M 139 181 109 130 + + NIL NIL 8.1 6.1 
28 6643 Siva 46/M 168 299 140 180 ++ +++ + + 13.1 8.5 
29 3360 Angamuthu 44/M 140 256 110 160 + +++ NIL NIL 8.9 6.5 
30 1177 Gowri shankar 39/M 120 168 90 142 NIL + NIL NIL 6.8 6.1 
31 899 Saroja 55/F 133 249 100 160 + ++ NIL NIL 7.6 6.4 
32 3376 Kumar 53/M 162 258 120 160 + ++ + NIL 10.1 7.2 
33 1096 Vasantha 46/F 198 311 120 200 ++ +++ + ++ 10.3 7.2 
34 2130 Chandran 49/M 131 169 97 131 NIL + NIL NIL 7.2 6.2 
35 5047 Kalalakshmi 52/F 140 210 100 160 + ++ NIL NIL 8.3 7.1 
36 8762 Rajagopal 56/M 170 200 120 150 ++ ++ NIL NIL 8.1 7 
37 3311 Prabakaran 47/M 158 195 108 160 + ++ NIL NIL 8.1 6.7 
38 9666 Thilagavathi 58/F 142 194 110 140 + + NIL NIL 8.3 7 
39   9665 Selvi 60/F 128 278 84 132 NIL +++ NIL NIL 9.1 6.8 
40 3183 Yuvaprasad 53/M 130 210 110 160 + ++ NIL NIL 7.9 6.5 
 
BT – Before Treatment, AT – After Treatment, N – Nil F- Fasting, PP- Post Prandial,  
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LABORATORY INVESTIGATION REPORT OF THE PATIENTS 
S.no O.P no Name Age / Sex 
Before treatment After Treatment ESR (mm) Hb (gms%) Urine Analysis 
TC 
(cu/mm 
DC TC 
(cu/mm 
DC BT AT 
BT AT 
BT AT 
P% L% E% P% L% E% ½ hr 1 hr ½ hr 1 hr Alb Dep Alb Dep 
1 4846 Babu 57/M 9400 57 39 4 9500 58 39 3 3 18 3 10 10 10.5 N FEC N FEC 
2 7150 Paramanantham 59/M 
9500 58 38 4 9600 60 37 3 6 10 5 6 11 12 N FEC N FEC 
3 3479 Kuppammal 58/F 9200 56 42 2 9400 62 36 2 8 10 4 5 11.6 12 N FPC N N 
4 435 Elumalai 42/M 9800 62 35 3 9700 63 36 1 8 12 4 10 13 13.8 N FEC N FEC 
5 3234 Selva kumar 54/M 
9600 62 33 5 9700 60 35 5 3 5 5 7 8 9.9 N FPC N N 
6 9440 Kasturi 67/F 
9700 59 37 4 9800 60 38 2 12 20 7 15 10 10.6 N FEC N N 
7 6020 Renuga devi 42/F 9800 58 37 5 9900 61 36 3 5 10 3 8 11 11.6 N FEC N FEC 
8 7157 Mohanam 55/M 9400 66 29 5 9500 67 32 1 10 20 5 10 10 11 N FPC N N 
9 2010 Mabubasha 52/M 
8400 56 36 8 8600 58 38 4 2 8 2 4 9 10 N FEC N FEC 
10 8963 Anandhi 44/F 9100 62 31 7 8900 61 37 2 3 10 5 10 10 11 N FEC N N 
11 3583 jagadesh 36/M 8600 54 44 2 8700 56 42 2 12 22 10 6 10 10.9 N FPC N N 
12 402 Subathra 50/F 8200 59 34 7 8300 59 40 1 7 12 3 10 11 12 N FEC N FEC 
13 2536 Regina mary 58/F 
9900 66 32 2 9800 61 37 2 3 5 3 10 12 12.6 N FPC N N 
14 2443 suresh 49/M 8400 63 37 3 8600 58 39 3 5 10 5 8 12 12.5 N FEC N N 
15 7432 Mahalakshmi 41/F 9400 62 32 4 9500 63 34 3 4 8 3 8 10 10.4 N FPC N N 
16 3565 Manjula 40/F 
8800 56 38 6 8900 61 37 2 10 20 5 10 8.8 9.4 N FPC N N 
17 5471 Rajendran 39/M 9600 63 33 4 9800 64 34 2 7 14 5 10 11 12 N FEC N FEC 
18 7899 Malliga 50/F 9500 62 36 2 9600 63 35 2 2 10 2 8 12 12.4 N FEC N N 
19 5045 Sasikala 45/F 9700 56 40 4 9600 59 39 2 6 12 3 6 10 10.2 N FPC N N 
20 3169 Kannan 37/M 
9400 60 36 4 9500 61 38 1 16 20 8 12 9.8 9.6 N FEC N FEC 
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Sl. 
no 
O.P no Name Age / Sex Before treatment After Treatment ESR (mm) Hb (gms%) Urine Analysis 
TC 
(cu/mm 
DC TC 
(cu/mm 
DC BT AT  
BT 
 
AT BT AT 
P% L% E% P% L% E% ½ hr 1 hr ½ hr 1 hr Alb Dep Alb Dep 
21 3368 Sujatha 46/F 10100 60 32 8 10000 65 32 3 12 24 6 12 12 12.6 N FEC N FEC 
22 49 Shanmugam 53/M 9600 61 37 2 9700 62 36 2 8 14 4 10 10 10.6 N FPC N N 
23 8738 Sibu 45/M 9000 55 39 6 9200 59 39 2 2 8 2 6 11 11.2 N FEC N FEC 
24 9398 Ganesan 43/M 9200 56 42 2 9300 58 40 2 3 8 3 6 12 12.4 N FEC N N 
25 9946 Shanmugapriya 36/F 8100 61 37 2 8200 61 38 1 4 10 6 8 9 10 N FEC N N 
26 307 Babu 48/M 8400 55 38 7 8600 60 38 2 8 10 4 8 9 9.8 N FEC N FEC 
27 4905 Harikrishnan 42/M 9200 56 40 4 9400 58 40 2 12 16 6 8 8.8 9.6 N FPC N N 
28 6643 Siva 46/M 10000 59 35 7 10100 62 35 3 8 12 3 10 12 13 N FEC N FEC 
29 3360 Angamuthu 44/M 8900 58 40 2 8800 58 41 1 5 10 5 6 14 14.2 N FEC N N 
30 1177 Gowri shankar 39/M 9100 63 31 6 9300 66 32 2 10 16 5 10 12 12.4 N FEC N FEC 
31 899 Saroja 55/F 9500 62 36 2 9600 61 38 1 3 5 3 6 13 13.4 N FEC N N 
32 3376 Kumar 53/M 8600 62 37 1 8500 61 38 1 4 10 2 6 9 9.8 N FPC N N 
33 1096 Vasantha 46/F 9100 61 37 2 9300 59 38 3 2 4 4 8 12 12.6 N FEC N N 
34 2130 Chandran 49/M 8900 50 44 6 9000 55 43 3 8 10 6 8 9 10 N FEC N FEC 
35 5047 Kalalakshmi 52/F 9100 63 35 2 9400 61 37 2 4 7 5 10 11 12 N FEC N FEC 
36 8762 Rajagopal 56/M 9500 52 41 7 9700 56 41 3 3 8 4 12 10 10.4 N FPC N N 
37 3311 Prabakaran 47/M 10200 60 38 2 10300 61 37 2 8 14 6 12 12 13 N FEC N FEC 
38 9666 Thilagavathi 58/F 9100 55 39 4 9400 57 40 3 8 14 4 10 10 10.2 N FEC N N 
39  9665 Selvi 60/F 8600 58 34 8 8900 62 36 2 3 6 3 8 11 12 N FPC N N 
40 3183 Yuvaprasad 53/M 8200 60 36 4 8500 61 36 3 8 16 4 8 10 10.4 N FPC N N 
 
BT – Before Treatment, AT – After Treatment, N – Nil, TC – Total Blood Count, DC – Differential 
Blood Count, P – Polymorphs, L – Leucocytes, 
E – Eosinophils, ESR – Erythrocytes Sedimentation Rate, mm – Milli meter,Hb – Hemoglobin, Alb 
– Albumin, Sug – Sugar, Dep – Deposits,  
FEC – Few Epithelial cells, FPC – Few Pus cells 
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DISCUSSION 
Madhumegam, is a clinical entity described byYugimunivar in his 
YugiVaidhyaChintamani 800 can be compared with Diabetes mellitus. The classical 
symptoms are  Polyuria,Polyphagia,Polydipsia,Itching all over the body,Pain all over the 
body ,Emaciation and Peripheral neuritis.        
In my study, 40 patients with Madhumegam were selected in the Department of 
PothuMaruthuvam , Government Siddha Medical College, attached to Arignar  Anna 
Govt  Hospital for Indian Medicine,Arumbakkam,  Chennai -106.    
All necessary investigations were carried out to all patients and trial medicine  
was given. The results of  before and after treatment of all the patients were analysed and  
discussed below. 
 
Age and Kaalam distribution: 
It shows that Madhumegam is seen in the age group of 41-50 yrs(45%), 51-60 
years (37.5) ,30-40 years(15%)and  2.5% in 61-70 yrs . 
Sex distribution: 
Out of 40 patients, 23 cases (57.5%) were male and 17 cases (42.5%) were 
female. 
Socio-economic status 
             Regarding socio-economic status,20 patients (50%) comes under middle class 
category, 13 patients (32.5%) comes under poor category, and 7 patients (17.5%) comes 
under high class category.    
Occupational status:        
            Of 40 patients,18 patients(45%) were office going, 7 patients (17.5%) were 
housewife, 7 patients (17.5%) were labourers and 8 patients (20%) were doing business. 
Diet: 
32 patients (80%) takes mixed diet and 8 patients (20%) take vegetarian diet. 
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Body built: 
Regarding bodybuilt, 29 patients(72.5%) were having normal weight, 6 
patients(15%) were overweight and 5 patients(12.5%) were lean. 
Family history: 
Regarding Family history,  28 patients(70%) had no family history of Diabetes,6 
patient‟s father(15%) and 6 patient‟s mother(15%) is diabetic. 
Thinai reference: 
Out of 40 patients, 36 patients (90%) comes under Neithalnilam and 4 
patients(10%) comes under Maruthanilam. 
Paruvakaalam: 
From selected 40 patients, 21 patient (52.5%) comes under Munpani 2 patients 
(5%) comes under Koothirkaalam, 6 Patients (15%) comes under Pinpani 3 patients 
(7.5%) comes under Kaarkaalam, 4 patients comes under Elavenil and Mudhuvenil each. 
The seasonal variation has no impact on Madhumegam.  
Duration of illness: 
Out of 40 patients, 16 patients (40%) belongs to 3 to 6 months category,10 
patients (25%) belongs to newly identified category, 7 patients (17.5%) belongs to 6 
months to one year  category and 7 patients (17.5%) belongs to more than one year 
category. 
Mukkutram classification: 
Vali: 
1. Abanan affected in all patients (100%) causing Polyuria, 
Nocturia,Constipation. 
2. Viyanan affected in all patients (100%)with Pain all over the body. 
3. Samanan and Kirukaran affected in all patients(100%) causing  Polyphagia. 
4. Devethathan affected in all patients(100%) causing disturbed sleep,fatigue. 
5. Koorman affected in 6 patients(15%) causing dimness of vision. 
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Azhal: 
1. Analagam affected in all patients(100%) causing polyphagia. 
2. Sathagam affected in all patients(100%) causing  lassitude. 
3. Ranjagam,Aalosagam and Prasagam affected in (20%),(15%),(10%) patients 
causing pallor,dimness of vision and dry skin  respectively. 
Iyyam: 
1. Kilethagam affected in all patients (100%) results in Polyphagia. 
2. Santhigam affected in 26 patients(65%) causing joint pain. 
Ezhuudalthathukkal: 
1. Saaram affected in all patients results in tiredness,general debility. 
2. Senneer affected in all cases causing pallor,dryness. 
3. Oon and Kozhuppu affected in 4 patients (10%) each causing emaciation 
4. Enbu affected in 28 patients (70%) causing  joint pain.    
Envagaithervugal: 
1. NaaNaadi,andMoothiram affected in all  40 patients(100%). 
2. Malam affected in 8 patients (20%)results in constipation. 
3. Vizhi was affected in 6 patients dimness of vision,(15%),Sparisam affected in 
6 patients(15%)  causing dry skin. 
 
Naadi:  
26 patients(70%) had PithaVathaNaadi and 8 patients(20%) had VathaPithanaadi 
and 6 patients(15%) had PithaKabanaadi. 
Neikuri: 
10 patients (25%) had Kabha neer,20 patients (50%) had Pithaneer, 10 patients 
(25%) had Vathaneer. 
Signs and symptoms: 
Polyuria, Polyphagia, Polydipsia, dryness of the mouth and throat and disturbed 
sleep present in all cases i.e 100%. Pain all over the body in 34 patients (85%), Itching 10 
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patients (25%), Constipation 8 patients (20%), emaciation 4 patients (10%) and 
Peripheral neuritis 10 patients (25%). Pruritis vulvae 4 patients (10%).  
Clinical prognosis: 
The clinical signs and symptoms were improved after treatment showing only 
17.5% had polyurea, 12.5% had polyphagia, 10% of the people had polydipsia, 17.5% 
have  pain all over the body, 10% have peripheral neuritis and 15% had disturbed sleep.  
Pruritis vulvae, itching all over the body, dryness of mouth and constipation were 
completely relieved.  
Laboratory assessment: 
Urine sugar Fasting and Postprandial became normal in 82.5% and 75% of 
patients respectively. 
Blood sugar Fasting and Postprandial controlled in 62.5% and 47.5% of patients 
respectively. 
HbA1C level reduced in 55% of cases  which shows good control in 
Madhumegam. 
Investigations: 
Investigations like TC, DC, ESR, Hb, Serum cholesterol and Blood urea,   were 
examined and urine analysis for albumin, sugar and deposits were also examined. Blood 
sugar Fasting,Post prandial, HbA1C were examined. 
Trial medicine: 
Naval kottaichoornam 1g,BD with warm water after food  was administered  for 
90 days. 
Suvaimukkutram theory: 
Madhumegam is due to derangement of Pitham and Kabakutram.The trial drug 
chosen has Kaippu  and thuvarpusuvai which settles down deranged kutrams. 
Biochemical analysis: 
It reveals the presence of  Ferrous iron, calcium, Potassium and alkaloids. 
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Toxicological study: 
Acute oral toxicity study followed as per OECD 423 guidelines and Sub acute 
oral toxicity study done as per OECD 407 guidelines revealed no toxicity in the trial 
medicine. 
. 
Pharmacological study: 
Pharmacological activity  is screened against Streptozotocin induced Diabetes in 
rat model. This proves that the trial medicine has Anti-diabetic activity. 
Clinical Study: 
All the patients were treated with Naval kottaichooranam  for an average of 
90days. All necessary laboratory investigations were again repeated, after the completion 
of treatment and showed significant improvement in clinical manifestations of 
Madhumegam. 
Bio statistical analysis: 
The p value is highly significant (p<0.001). So there is significant reducing of 
Fasting and Postprandial blood sugar level (mg) among the patients for the treatment of 
Madhumegam.Hence it is concluded that the treatment was effective and significant. 
Grading of results: 
Out of 40 patients, 70% of cases showed good result, 20% of the cases showed 
Moderate result and 10% showed mild result. 
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SUMMARY 
The clinical study on Madhumegam was carried out in the Post Graduate 
department of Maruthuvam,Govt Siddha Medical College,Arignar Anna Hospital, 
Chennai-106, during the period of 2014-2016. 
 
A total of 40 patients were treated in the O.P and I.P department. the clinical and 
pathological  assessment  was carried out on the basis of both Siddha and Modern 
aspects. 
All the 40 patients were treated with naval kottai Chooranam, 1g BD with warm 
water for 90 days. The responses were assessed once in 15 days for all the patients. 
 
 The peak incidence of Madhumegam was in 51-60 yrs (37.5%) in both sexes. 
 The prevalence was higher among the middle class 50%, poor 32.5% and high 
class population 17.5%. 
 Out of 40 patients, 45% were office going, housewives 17.5%,, labourers17.5% 
and business people were 20%. 
 Regarding diet, 80% takes mixed diet and 20% takes vegetarian diet. 
 Regarding family history 70% had no relavent history,15% of father is diabetic 
and 15% of mother is diabetic. 
 Out of 40 patients,92.5% comes underPitha kaalam,5% comes under  Vatha 
kaalam and  2.5% comes under Kaba kaalam 
 In Vatham-Abanan,Viyanan,Samanan,Kirukaran and Devathathan were affected 
100%,Koorman 15% was affected. 
 In Pitham-Analagam and Sathagam were 100% 
affected.Ranjagam(20%),Alosagam (15%),prasagam(10%) were affected. 
 In Kabam, Kilethagam(100%) and Santhigam(65%) were affected. 
 Among the EzhuudalthathukkalSaaram,Seneer were 100% affected,Enbu(70%), 
Oon(10%),Kozhuppu(10%) were affected. 
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 Regarding EnvagaithervugalNaaNaadi, and Moothiram were 100% affected 
Malam 20%,Vizhi(15%) Sparisam(15%) were affected. 
 Naadi in Madhumegam was PithaVathanaadi(65%), VathaPithanaadi 20% and 
PithaKabam 15%. 
 In Neikuri examination 25% showed Vathaneer, 50% had pithaneer and 25% 
showed kabaneer. 
 The clinical trial shows that there is significant improvement in clinical 
manifestations of Madhumegam. 
 Urine sugar Fasting and Postprandial became normal in 82.5% and 75% of 
patients respectively. 
 Regarding Blood sugar level fasting and post prandial blood sugar reduced in 
62.5% and 47.5% of the cases. 
 HbA1C level improved in 55% of cases (5.7-7%) which shows good control in 
Madhumegam. 
 The Ingredients of trial medicine have the properties  to control Blood sugar level. 
 The Toxicological study of trial medicine revealed no toxicity. 
 The Pharmacological study shows anti diabetic activity in Streptozotocin induced 
diabetic rats. 
 The Bio-statistical report of the clinical trial shows significant p value< 0.001 and 
hence the treatment was effective and significant. 
 Among 40 cases, 67.5% of the patients showed good result, 15% moderate result 
and 17.5% showed mild result. 
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CONCLUSION 
 Madhumegamis primarily due to derangement of Pitham and Kabam 
 The trial medicine naval kottaichooranam has property of neutralizing deranged 
Kutrams. 
 From preclinical studies the trial medicine revealed no toxicity in animal model 
and proved to be safe in human subjects. 
 From preclinical Pharmacological studies, the trial medicine has anti-diabetic 
activity. 
 During the clinical study no contraindication was reported 
 The trial medicine significantly reduced blood sugar level and other symptoms. 
 The trial medicine is cost effective and palatable. 
Hence I conclude that trial drug will be a better drug that can be used in  the treatment of  
Madhumegam.    
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HPTLC REPORT OF NAVALKOTTAI CHOORANAM 
Solvent system : Toluene : Ethyl acetate : Formic acid (5:1:0.5) 
 
 
 
UV 254 nm UV 366 nm After dipping in Vanillin-sulphuric 
acid reagent 
   
Rf Color Rf Color Rf Color 
0.08 Dark 0.04 Brown 0.20 Light Pink 
0.11 Dark 0.06 Light Pink 0.40 Light Blue 
0.22 Dark 0.1 Pink 0.49 Dark 
0.27 Dark 0.21 Florescent Green 0.69 Dark 
0.69 Dark 0.26 Green   
  0.34 Light Green   
  0.37 Light Red   
  0.41 Light Green   
  0.45 Red   
  0.49 Green   
  0.57 Red   
  0.72 Blue   
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
Preparation of Sodium Carbonate extract: 
2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken in a 100 ml 
beaker and 20 ml of distilled water is added. The solution is boiled for 10 minutes, cooled 
and then filtered. The filtrate is called sodium carbonate extract. 
S.No EXPERIMENT OBSERVATION INFERENCE 
I                                    TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared 
extractis taken in a test tube. To 
this add2ml of 4% Ammonium 
oxalatesolution. 
Absence of 
White Precipitate 
Absent 
b 2ml of extract is added with 2ml 
of dilute hydrochloric acid until 
the effervescence ceases off. 
Then2ml barium chloride solution 
isadded. 
Absence of 
White Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with 
dilutenitric acid till the 
effervescenceceases. Then 2ml of 
silver nitratesolution is added. 
 Absence of 
white precipitate 
 
Absent 
3 Test for Phosphate 
2ml of the extract is treatedwith  
2 ml of Ammoniummolybdate 
solution and 2ml ofconcentrated 
nitric acid. 
 
Absence of 
Yellow precipitate 
 
Absent 
4 Test for Carbonate: Absence of white Absent 
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2ml of the extract is treatedwith 
2ml of magnesiumsulphate 
solution. 
precipitate 
5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentratedHcl. 
Absence of Rotten 
egg smelling 
Absent 
6 Test for Nitrate: 
1gm of the substance is heatedwith 
copper turnings andconcentrated 
sulphuric acidand viewed the test 
tubevertically down. 
Absence of reddish 
brown gas. 
Absent 
 
7a Test for Fluoride and oxalate 
2ml of the extract is added with2ml 
of dilute acetic acid and2ml of 
calcium chloridesolution and 
heated. 
Absence of white 
precipitate 
Absent 
b 5 drops of clear solution isadded 
with 2ml of diluted sulphuric acid 
and slightlywarmed to this, 1 ml of 
dilutepotassium permanganate 
solution is added. 
Absence of 
Discolourisation 
Absent 
8 Test for Nitrite 
3 drops of the extract is placedon a 
filter paper. On that, 2 drops of 
Acetic Acid and 2drops of 
Benzidine solution isplaced. 
Absence of 
yellowish red colour 
Absent 
9 Test for Borate 
2 pinches of the substance ismade 
into paste by usingSulphuric acid 
and Alcohol(95%) and introduced 
Absence of Green 
tinged flame 
Absent 
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into theblue flame. 
II TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is addedwith 2 
ml of Potassium iodidesolution. 
Absence of Yellow 
precipitate 
Absent 
11a Test for Copper 
One pinch of substance ismade 
into paste withconcentrated 
Hydrochloric acidin a watch glass 
and introducedinto the non 
luminous part ofthe flame. 
Absence of Bluish 
green coloured 
flame. 
Absent 
b 2ml of the extract is added 
withexcess of Ammonia solution 
 
Absence of deep 
blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. 
SodiumHydroxide solution is 
added indrops to excess 
Absence of White 
Precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml 
ofAmmonium 
ThiocyanateSolution is added. 
Presence of Blood 
red colour 
Present 
b To the 2 ml of extract, 2 ml 
ofAmmonium Thiocyanatesolution 
and 2 ml ofconcentrated Nitric 
Acid isadded. 
Blood red colour 
obtained 
Present 
14 Test for Zinc 
To the 2 ml of extract 
SodiumHydroxide solution is 
added indrops to excess. 
Absence of White 
Precipitate. 
Absent 
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15 Test for Calcium 
2 ml of the extract is addedwith 2 
ml of 4% AmmoniumOxalate 
solution. 
Presence of White 
Precipitate. 
Present 
16 Test for Magnesium 
2ml of extract, SodiumHydroxide 
solution is added indrops to excess. 
Absence of White 
Precipitate. 
Absent 
17 Test for Ammonium 
2 ml of extract few ml of Nessler‟s 
Reagent and excess of Sodium 
Hydroxide solution are added. 
Absence of 
Reddish brown 
precipitate 
Absent 
18 Test for Potassium 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 2ml 
of Cobal Nitrate in 30%glacial 
Acetic acid. 
Presence of Yellow 
precipitate 
 
Present 
19 Test for Sodium 
2 pinches of the substance is made 
into paste by using Hydrochloric 
acid and introduced into the blue 
flame. 
 
Absence of Yellow 
colour flame 
Absent 
20 Test for Mercury 
2 ml of the extract is treatedwith 2 
ml of Sodium Hydroxide solution. 
Absence of yellow 
precipitate 
Absent 
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21 Test for Arsenic 
2 ml of extract is treated with 2ml 
of silver Nitrate solution. 
Absence of 
Yellow precipitate 
Absent 
22 Test for Starch 
2ml of extract is treated with weak 
iodine solution 
Absence of 
Blue colour 
Absent 
23 Test of reducing Sugar 
5ml of Benedicts qualitative 
solution is taken in a test tube and 
allowed to boil for 2minutes and 
added 10 drops of the extract and 
again boiled for2 minutes. The 
colour changes are noted. 
Absence of Green 
colour 
Absent 
24 Test of the alkaloids 
2ml of the extract is treated with 
2ml of potassium lodide solution. 
Presence of 
Red colour 
Present 
25 Test of the proteins 
2ml of the extract is treated with 
2ml of 5% NaOH,mix well and 
add 2 drops of copper sulphate 
solution. 
Absence of 
Violet colour 
Absent 
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RESULTS: 
The given sample (Naval Kottai Chooranam) contains  
Iron 
Calcium 
Potassium 
Alkaloids 
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Toxicity study 
ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423 
Animal : Healthy wistar albino female rat weighing 220–240 gm 
Studied carried out at three female rat under fasting condition, signs of toxicity 
was observed for every one hour for first 24 hours and every day for about 14 days from 
the beginning of the study. 
INTRODUCTION:  
The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a singlesex per step. Depending on the mortality and/or the moribund status of the 
animals, on average 2-4 steps may be necessary to allow judgment on the acute toxicity 
of the test substance. Morbid animals or animals obviously in pain or showing signs of 
severe and enduring distress shall be humanely killed, and are considered in the 
interpretation of the test  results  in  the  same  way  as  animals  that  died  on  test.  The 
method allows for the determination of an LD50 value only when at least two doses result 
in mortality higherthan 0% and lower than 100%. 
PRINCIPLE:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum  number  of  animals  per  step,  sufficient  information  is  obtained  on  the  
acute toxicity  of  the  test  substance  to  enable  its  classification.  The substance is 
administered orally to a group of experimental animals at one of the defined doses.  The 
substance is tested using a stepwise procedure, each step using three animals of a single 
sex. Absence or presence of compound-related mortality of the animals dosed at one step 
will determine the next step, i.e.; − no further testing is needed − dosing of three 
additional animals with the same dose − dosing of three additional animals at the next 
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higher or the next lower dose level. The method will enable a judgment with respect to 
classifying the test substance to one of a series of toxicity classes.   
METHODOLOGY   
Selection of animal species:  
The preferred  rodent species is rat, although other rodent species may be used.  
Healthy  young  adult  animals  of  commonly  used  laboratory  strain Swiss albino is 
used .  Females should be nulliparous and non-pregnant.  Each animal at the 
commencement of its dosing should be between 8 and 12 weeks old and its weight should 
fall in an interval within±20 % of the mean weight of the animals.   
Housing and feeding conditions:   
 The  temperature  in  the  experimental  animal  room  should  be  22ºC  (+3ºC). 
Although  the  relative  humidity  should  be  at  least  30%  and  preferably  not  exceed  
70% other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hrs  light, 12 hrs dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals may be 
grouped and tagged by dose, but the number of animals per cage must not interfere with 
clear observations of each animal.   
Preparation of animals:   
  The animals are randomly selected, marked to permit individual identification, and kept 
in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions.  
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Observation done: 
Group Day 
Body weight Normal 
Assessments of posture Normal 
Signs of Convulsion 
Limb paralysis 
Absence of sign (-) 
Body tone Normal 
Lacrimation Absence 
Salivation Absence 
Change in skin color No significant colour change 
Piloerection Normal 
Defecation Normal 
 Sensitivity response Normal 
Locomotion Normal 
Muscle gripness Normal 
Rearing Mild 
Urination Normal 
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1.Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6. Touch 
Response 7. Decreased Motor Activity   8.Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia115.Lacrimation 
16. Exophthalmos 17. Diarrhoea   18. Writhing   19 Respiration   20.  Mortality 
Acute toxicity: 
In the acute toxicity study, the rats were treated with different concentration of naval 
kottaichooranam from the range of 5mg/kgto 2000mg/kg which did not produce signs of 
toxicity, behavioral changes, and mortality in the test groups as compared to the controls 
when observed during 14 days of the acute toxicity experimental period. These results 
showed that a single oral dose of the extract showed no mortality of these rats even under 
higher dosage levels indicating the high margin of safety of this extract. In acute toxicity 
test the naval kottaichooranam was found to be non toxic at the dose level of 2000mg/ kg 
body weight. 
 
 
 
 
 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
2000 + - - - - + - - - - - - - + - - - - - - 
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SUB-ACUTE TOXICITY 
The dose selected for the sub acute toxicity study was 100mg, 200mg/kg of 
Naval kottaiChooranam. All the animals were free of intoxicating signs throughout 
the dosing period of 28 days. No physical changes were observed throughout the 
dosing period. No mortality was observed during the whole experiment. No abnormal 
deviations were observed. No significant changes were observed in the values of 
different parameters studied when compared with controls and values obtained were 
within normal biological and laboratory limits. The weights of organs recorded did 
not show any significant differences in the treatment and the control group indicating 
that Naval kottaiChooranamwas not toxic to kidney, liver and spleen There was no 
significant changes were observed in hemoglobin (Hb), red blood cell (RBC), white 
blood cell (WBC), packed cell volume (PCV), Erythrocyte sedimentation rate (ESR) 
in all the treated groups as compared to respective control groups.  
SUB ACUTE REPORTS 
Naval kottai chooranam (100mg/kg) 
HAEMOTOLOGY 
CBC 
WBC    :   5,300 cells/cumm 
Differential Count 
NEUTROPHILLS  : 10% 
LYMPHOCYTES  : 89 % 
EOSINOPHILS  : 01 % 
MONOCYTES  : 00 % 
RBC    : 9.37millions/cumm 
HB    : 16.6gms%  
PCV    : 50.4 % 
 131 
 
MCV    : 53.8fL 
MCH    : 17.7pg  
MCHC  : 32.9 Grams/dl  
PLATELET   : 7.4 Lakhs/cumm 
BIOCHEMISTRY 
Blood sugar   :  92 mg/dl 
BUN    :  32.1 mg/dl 
Creatinine   :  0.9 mg/dl 
SGOT   :  90  U/L 
SGPT    :  78  U/L 
ALP    :  161    U/L 
T.Protein   :  6.7  grams/dl 
Albumin   :  3.5  grams/dl 
LIPID PROFILE 
T. Cholesterol  :  112 mg/dl 
Triglycerides  :  78  mg/dl 
HDL   :  28 mg/dl 
LDL   :  68.4  mg/dl 
VLDL   :  15.6  mg/dl 
Ratio 1(T.CHO/HDL)   :  4.0 
Ratio 2(LDL/HDL) :  2.44 
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  HISTOPATHOLOGICAL REPORT 
Naval kottai chooranam 
(100mg/kg) 
Kidney   Liver   Spleen                pancreas 
 
 
Naval kottai chooranam 
(200mg/kg) 
HAEMOTOLOGY 
CBC 
WBC    :   8,700 cells/cumm 
Differential Count 
NEUTROPHILLS  : 15% 
LYMPHOCYTES  : 84 % 
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EOSINOPHILS  : 01 % 
MONOCYTES  : 00 % 
RBC    : 7.08millions/cumm 
HB    : 14.5gms%  
PCV    : 44.7 % 
MCV    : 63.1fL 
MCH    : 20.5pg  
MCHC  : 32.4 Grams/dl  
PLATELET   : 6.53 Lakhs/cumm 
BIOCHEMISTRY 
Blood sugar   :  90 mg/dl 
BUN    :  42.5 mg/dl 
Creatinine   :  0.7 mg/dl 
SGOT   :   90 U/L 
SGPT    :  60  U/L 
ALP    :  101    U/L 
T.Protein   :  7.2  grams/dl 
Albumin   :  3.5  grams/dl 
LIPID PROFILE 
T. Cholesterol  :  101 mg/dl 
Triglycerides  :  67  mg/dl 
HDL   :  24 mg/dl 
LDL   :  63.6  mg/dl 
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VLDL   :  13.4  mg/dl 
Ratio 1(T.CHO/HDL)   :  4.21 
Ratio 2(LDL/HDL) :  2.65 
 
Histopathology 
Pancreas                     Kidney                             
 
Liver                             Spleen 
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PHARMACOLOGICAL ACTIVITY 
ANTI DIABETIC ACTIVITY 
 
Experimental Design: 
Diabetes was induced using Streptozotocin (100 mg/kg). Only 
Streptozotocinised  animals were used for further studies. Animals were fasted for 18 
h before the experiment and divided into 5 groups (6 animals in each group). 
 
 
Effects on Blood Glucose Levels 
Diabetes was induced by the intravenous administration of streptozotocin (100 
mg/kg)
1, 2
after anaesthesia with ethyl ether. Forty-eight hours later, the blood (1 mL) 
was collected from the orbital sinus into tubes and immediately usedfor the 
determination of glucose. Only animals that presented with glycaemic levels equal to 
or above 200 mg/dL were submitted to treatments,which consisted of a daily 
administration of naval kottaichooranam for 7 days. The oral treatments (by gavage) 
of all groups were carried out at the same time (in the morning) used. One hour after 
the lastadministration, the blood was collected again for blood glucose measurements 
using a glucometer 
 
 
 
Groups Treatment 
Group I Normal Control 
Group II Diabetic control- Streptozotocin (100 
mg/kg ) 
Group III Diabetic control- glibenclamide (5 mg/kg) 
Group IV Diabetic control- Naval kottaichooram 
200mg/kg  
Group V Diabetic control-  Naval kottaichooram 
400mg/kg  
 137 
 
References: 
Effect of Naval kottaichooranam on plasma glucose Levels on rats 
Groups Blood Glucose Levels (mg %) 
1
st
 day 
 
3
rd
 day 
 
7
th
 day 
Control 90.33±0.88 90.66±2.40 91.33±3.52 
Alloxan Control 99.66±10.17 326.66±24.03 *** 340.00±30.55 *** 
Glibenclamide 5 
mg/kg 
88.68±2.90 107.33±3.52 97.33±2.90 
Naval 
kottaichooranam 
(200mg/kg) 
94.66±2.90 110.33±15.30 114.00±11.37 
Naval 
kottaichooranam 
(400mg/kg) 
93.00±2.08 102.00±10.39 106.66±2.40 
N=6 ;Statistical analysis one way ANOVA followed by Dunnett t-test. ***P<0.01 as compared with 
day1. 
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Oral glucose tolerance test: 
 Oral glucose tolerance test (OGTT) was performed in overnighted fasted 
normal rats as per reported method. The blood glucose levels were determined by 
using glucometer by using strips 
3 
 
Groups Oral Glucose Tolerance Test 
O min 30 min 60 min 120 min 
Control 90.46± 2.48 130.16± 12.14 240.56± 2.68 120. 14± 3.78 
Glibenclamide 92.09± 5.65 108.56± 5.78 79.67± 4.17 64.56± 4.89 
Naval 
kottaiChooranam 
200 mg/kg 
92.56± 2.48 115.16± 2.14 88.14± 7.78 86.14± 8.98 
Naval 
kottaiChooranam 
400 mg/kg 
94.16± 7.78 108.14± 3.14 80.68± 3.14 76.14± 4.56 
N=6 ;Statistical analysis one way ANOVA followed by Dunnett t-test. ***P<0.01 
 
                                        Groups 
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Histopathological slides of pancreas 
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1- Normal rats 
2- Streptozotocin induced rats 
3- Glibenclamide 5 mg/kg 
4- Naval kottaichooranam (200mg/kg) 
5- Naval kottaichooranam (400mg/kg) 
Interpretation : 
 Group I- Normal Saline treated rats showed using with 
Haematoxylin & Eosin stained section shows pancreas with 
normal islets and acini 
 Group II- Streptozotocin  treated rats showed damaged and 
atrophic islet with acini. 
 Group III- Streptozotocin + Glibenclamide rats showed 
preserved and regenerated cells of islet with acini 
 Group IV- Streptozotocin + N. KottaiChooranam200mg/kg 
showed small damaged of pancreatic islet cells. 
 Group V- Streptozotocin+ N. KottaiChooranam 400mg/kg 
showed recovered of pancreatic islet cells. 
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CLINICAL PROGNOSIS 
Treatment for Madhumegam: 
The most popular non parametric statistical tool, namely, McNemar Test analysis has 
been employed to analyses the effectiveness with the help of a hypothesis. 
S. 
No 
Signs & Symptoms Before Treatment After Treatment 
n% n% 
1. Polyuria 40(100) 7(17.5)** 
2. Polyphagia 40(100) 5(12.5)** 
3. Polydipsia 40(100) 4(10)** 
4. Pruritis vulvae 4(10) 0(0)* 
5. Itching all over the body 10(25) 0(0)** 
6. Pain all over the body 34(85) 7(17.5)** 
7. Dryness of mouth and 
throat 
40(100) 0(0)** 
8. Constipation 8(20) 0(0)** 
9. Emaciation 4(10) 3(7.5) 
10. Peripheral neuritis 10(25) 4(10)* 
11. Disturbed sleep 40(100) 4(10) ** 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in signs and symptoms except emaciation.So 
there is significant reducing of signs & symptoms except emaciation among the 
patients for the treatment of Madhumegam.Hence it is concluded that the treatment 
was effective and significant. 
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Effect of Naval kottaichooranam on Fasting Blood Sugar level in Madhumegam 
cases 
S. no Fasting  blood sugar level in mg  
Before Treatment After Treatment 
1. 166 116 
2. 95 95 
3. 162  114 
4. 139 96 
5. 136 105 
6. 127 95 
7. 163 109 
8. 168 110 
9. 199 180 
10. 139 90 
11. 151 110 
12. 158 110 
13. 190 140 
14. 136 96 
15. 136 98 
16. 152 102 
17. 189 100 
18. 109 80 
19. 104 90 
20. 126 94 
21. 181 98 
22. 96 80 
23. 117 100 
24. 120 105 
25. 157 110 
26. 110 100 
27. 139 109 
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Software: spss17 version 
Variables: Fasting Blood Sugar Level (mg) – before treatment, after treatment 
Number of cases: 40 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.715 
Before and after treatment mean difference ±SEM: 38.60 ± 2.95 
P Value (2 tailed): p<0.001. 
Inference:  
          Since the p value is significant (p<0.001). The hypothesis is not accepted. So 
there is significant reducing of Fasting blood sugar level (mg) among the patients for 
the treatment of Madhumegam. Hence it is concluded that the treatment was effective 
and significant. 
 
28. 168 140 
29. 140 110 
30. 120 90 
31. 133 100 
32. 162 120 
33. 198 120 
34. 131 97 
35. 140 100 
36. 170 120 
37. 158 108 
38. 142 110 
39. 128 84 
40. 130 110 
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Effect of Naval kottaichooranam on Postprandial blood Sugarlevel in 
Madhumegam cases 
S. no Postprandial blood sugar level in mg 
Before Treatment After Treatment 
1. 262 240 
2. 276 180 
3. 258 182 
4. 299 140 
5. 280 140 
6. 172 130 
7. 298 138 
8. 242 160 
9. 289 249 
10. 199 142 
11. 187 140 
12. 256 176 
13. 272 191 
14. 190 126 
15. 190 142 
16. 241 162 
17. 289 180 
18. 142 120 
19. 213 150 
20. 212 138 
21. 288 142 
22. 168 140 
23. 170 120 
24. 180 150 
25. 263 160 
26. 160 130 
27. 181 130 
28. 299 180 
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Software: spss17 version 
Variables: Postprandial Blood Sugar Level (mg) – before treatment, after treatment 
Number of cases: 40 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.585 
Before and after treatment mean difference ±SEM: 73.52 ± 6.23  
P Value (2 tailed): p<0.001. 
Inference:  
Since the p value is significant (p<0.001). The hypothesis is not accepted. So there is 
significant reducing of postprandial blood sugar level (mg) among the patients for the 
treatment of Madhumegam.Hence it is concluded that the treatment was effective and 
significant. 
 
 
29. 256 160 
30. 168 142 
31. 249 160 
32. 258 160 
33. 311 200 
34. 169 131 
35. 210 160 
36. 200 150 
37. 195 160 
38. 194 140 
39. 278 132 
40. 210 160 
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Effect of Naval kottaichooranam on HbA1C level in Madhumegam cases 
S. no HbA1C 
Before Treatment After Treatment 
1. 8.9 7.8 
2. 11.2 7.2 
3. 8.3 6.9 
4. 9.6 6.2 
5. 9.5 6.4 
6. 6 5.8 
7. 10.2 8.2 
8. 10.4 8.1 
9. 11.6 8.8 
10. 8 6.5 
11. 7.7 6.2 
12. 9.1 7.6 
13. 11.2 7.8 
14. 8.3 6.9 
15. 6.9 6.1 
16. 9.2 7.1 
17. 11 7.3 
18. 6.5 6.1 
19. 6.7 6.2 
20. 9.5 4.9 
21. 9.8 7.1 
22. 6.4 6.1 
23. 6.7 6.2 
24. 6.5 6.1 
25. 8.21 6.2 
26. 6.7 6.1 
27. 8.1 6.1 
28. 13.1 8.5 
29. 8.9 6.5 
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Software: spss17 version 
Variables: HbA1C Level – before treatment, after treatment 
Number of cases: 40 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.741 
Before and after treatment mean difference ±SEM: 1.87 ± 0.19 
P Value (2 tailed): p<0.001. 
Inference:  
Since the p value is significant (p<0.001). The hypothesis isnot accepted. So there is 
significant reducing of HbA1C level among the patients for the treatment of 
Madhumegam.Hence it is concluded that the treatment was effective and significant. 
 
 
 
30. 6.8 6.1 
31. 7.6 6.4 
32. 10.1 7.2 
33. 10.3 7.2 
34. 7.2 6.2 
35. 8.3 7.1 
36. 8.1 7 
37. 8.1 6.7 
38. 8.3 7 
39. 9.1 6.8 
40. 7.9 6.5 
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CONSENT FORM 
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CONSENT FORM 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
DATE:        SIGNATURE 
         NAME 
CONSENT BY THE PATIENT 
 I have been informed to my satisfaction by the attending physician the purpose 
of the clinical trial and the nature of the drug treatment and follow up including the 
lab investigations to be performed to monitor and safeguard my body functions. 
I am aware of my right to opt out of the trial at any time during the course of 
the trial without having to give reasons for doing so. 
I am exercising my free power of choice, and hereby give my consent to be 
included as a subject in the clinical trial of NAVAL KOTTAI CHOORANAM for 
the treatment of MADHUMEGAM. 
 
 
DATE:       SIGNATURE 
        NAME 
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nehahëæ‹ x¥òjš got© 
 ÂU-------------- M»a eh‹ ---- taJ--------------------
------------------------------------------------------------
--------------------- v‹ Ra ãidÎl‹ vGÂ¡bfhL¡F© x¥òjš 
got«. 
 eh‹ kJnkf« (ÚçêÎ)  v‹D© 
nehahšghÂ¡f¥g£Lbr‹idmuRÁ¤jkU¤Jtfšÿçæš(Ïl©: m¿P® 
m§zhkU¤Jtkid, mU©gh¡f©, br‹id- 106) el¤j¥gL« 
Á¤jkU¤JtMuhŒ¢Á _y© Á»¢irbgw v‹ KG r©kj¤ijÍ© 
bjçé¤J¡bfhŸ»nw‹. 
 Ï¨jMuhŒ¢Áæ‹ neh¡f©, kU¤Jt© brŒÍ© Kiwbjhlª 
f§fhâ¥òk‰W© v‹ clšey© F¿¤j kU¤Jtgçnrhjidfis g‰¿ 
éçthdés¡f« vd¡FkU¤Jt© brŒÍ© kU¤Jtª _y© 
bjëÎgL¤j¥g£LŸsJ.  Ï¨jMuhŒ¢Áæšg¦FbfhŸS© v‹ 
r©kj¤Â‰FahUilaãªg¨jK© 
fhuzKäšiyv‹gijbjçé¤J¡bfhŸ»nw‹. 
 
          Ï¥go¡F, 
bga® : 
Kftç: 
ehŸ: 
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CASE SHEET PROFORMA 
POST GRADUATE DEPARTMENT - BRANCH-I MARUTHUVAM 
GOVT. SIDDHA MEDICAL COLLEGE & ANNA HOSPITAL, CHENNAI-106. 
CASE SHEET PROFORMA FOR “MADHUMEGAM” 
Ward No. : Nationality : 
I.P. No :  Religion : 
Bed No : Occupation : 
Name : Income : 
Age : Date Of  
Sex : Admission : 
Permanent Address:  Date Of 
  Discharge : 
  Diagnosis : 
Temporary Address:  Medical Officer  
Govt. Siddha Medical College & 
Anna Hospital, Chennai – 106. 
 
Complaints And Duration : 
 
 
History Of Present Illness : 
 
 
History Of Past Illness : 
 
 
Personal History & Habits : 
 
 
 
Family History : 
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GENERAL EXAMINATION: 
1. Body built 
2. Consciousness  
3. Nourishment 
4. Decubitus 
5. Anaemia 
6. Jaundice 
7. Cyanosis 
8. Clubbing 
9. Lymphadenopathy 
10. Oedema 
11. Jugular venous pulsations 
12. Enlarged vein 
13. Miscellaneous  
VITAL SIGNS: 
14. Pulse rate 
15. Temperature 
16. Respiratory rate 
17. Heart  Rate 
18. Blood Pressure. 
SIDDHA ASPECTS 
NILAM (PLACES) 
1. Kurinchi (Moutains and their adjoining Areas) 
2. Mullai (Forest and their adjoining Areas) 
3. Marudham (Fertile  and their adjoining  Areas) 
4. Neithal (Sea and their adjoining Areas) 
5. Paalai (Desert and their adjoining Areas) 
PARUVA  KAALAM (SEASONS)  
1. KaarKaalam (Aavani-Puratasi) Aug-sept. 
2. KoothirKaalam (Iypasi-Karthigai) Oct-Nov. 
3. MunpaniKaalam (Maargazhi-Thai) Dec-Jan. 
4. ElavenilKaalam (Chithirai-Vaikasi) Apr-May 
5. MudhuvenilKaalam (Aani-Aadi) Jun-Jul 
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YAAKAI (UDAL) 
1. Valiudal 
2. Azhaludal 
3. IyyaUdal 
4. KalappuUdal 
UTKAYAM  (Athakkayam) 
1. Puyam 
2. Sayam 
3. Kall 
4. Patham 
GUNAM 
1. SathuvaGunam 
2. RajoGunam 
3. ThamoGunam 
IYAMPORIGAL  (SENSORY ORGANS)  
1. Mei  - Unarthal 
2. Vaai  - Suvaiththal 
3. Kan  - Parththal 
4. Mooku - Mugarthal 
5. Sevi - Kettal 
KANMENTHIRIYAM / KANMAVIDAYAM 
1. Kai   -  Koduththal 
2. Kaal  - Nadaththal 
3. Vaai  - Pesal 
4. Eruvai -  MalamKazhithal 
5. Karuvai – Aananthithal 
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KOSAM 
1. AnnamayaKosam 
(YeluudalThaathukkal) 
 
2. PranamayaKosam 
(Pranan + Kanmenthiriyam) 
 
3. ManomayaKosam 
(Manam + Gnanethiriyam) 
 
4. GnanamayaKosam 
(Puththi + Gnanenthiriyam) 
 
5. AnanthamayaKosam 
(Pranan + Suzhuthi) 
PIRA URUPUKALIN NILAI: 
1. Irudhayam 
2. Puppusam 
3. Eraippai 
4. Kalleral 
5. Manneeral 
6. Kudal 
7. Siruneeragam 
8. Karuppai 
9. Moolai 
UYIR THATHUKKAL: 
Vatham    
 1.Pranan 
       2. Abanan    
 3.Viyanan    
 4.Udhanan    
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 5.Samanan    
 6.Naagan 
7.Koorman    
 8.Kirukaran 
9. Devadathan 
10.Thanenjeyan 
PITHAM: 
1. Anal Pitham 
2. RanjagaPitham 
3. SaadhagaPitham 
4. AalosagaPitham 
5. PrasagaPitham 
KAPHAM: 
1. Avalambagam 
2. Kledagam 
3. Podhagam 
4. Tharpagam 
5. Santhigam 
UDAL THATHUKKAL: 
1. Saaram 
2. Senneer 
3. Oon 
4. Kozhuppu 
5. Enbu 
6. Moolai 
7. Sukkilam / Suronitham 
EnvagaiThervu: 
1. Naa - Niram 
  Thanmai 
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  Pulan  
2. Niram 
3. Mozhi - Thazhnthaoli 
  Urathaoli 
 
4. Vizhi - Niram 
5. Sparisam          -         Thanmai 
  Pulan 
 
6. Malam - Niram 
 Erugal  / Elagal 
 Manam 
 Nurai 
7. Moothiram 
a.   Neerkuri -     Niram, Manam, Edai, Nurai, Enjal 
b.   Neikuri 
8. Naadi -  ThaniNaadi 
  KalappuNaadi 
    MukkutraNaadi 
    ThondhaNaadi 
Systemic Examination: 
 1.Gastro intestinal system 
2.Cardio Vascular System 
3.Respiratory system 
4.Central Nervous System 
5.Genito-Urinary System 
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Signs and Symptoms: 
 
S.no Clinical 
Features 
Before 
treatment 
After treatment(Weeks) 
I II III IV V VI VII 
1. Polyuria         
2. Polyphagia         
3. Polydipsia         
4. Balanitis / 
Pruritis vulva 
        
5. Itching all over 
body 
        
6. Pain all over 
body 
        
7. Dryness of the 
mouth and throat  
        
8. Constipation         
9. Skin infection         
10 Emaciation         
11 Dry skin         
12 Peripheral  
Neuritis 
        
13 Ulcer in the foot         
14 Diabetic cataract         
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Laboratory Investigation: 
I. Blood   TC                                                     Blood urea 
             DC                                                    Serum cholesterol 
  ESR  
  Hb % 
  Sugar -Fasting      
   Post prandial  
  Glycosylated Haemoglobin (HbAIC) 
2.   Urine  
   Albumin 
    Sugar 
               Deposits. 
. 
CASE SUMMARY: 
 
FINAL DIAGNOSIS: 
 
MEDICINE: 
 NAVAL KOTTAI  CHOORANAM- 1g BD with warm water   
 
MEDICAL ADVICE      HOD 
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